<!-- conforms to schemas at:
https://eudract.ema.europa.eu/docs/technical/schemas/clinicaltrial/results/results.xsd
https://eudract.ema.europa.eu/docs/technical/schemas/clinicaltrial/results/adverseEvents.xsd -->
<result xmlns:ns3="http://eudract.ema.europa.eu/schema/clinical_trial_result" 
xmlns:ns2="http://eudract.ema.europa.eu/schema/clinical_trial_result/adverse_events" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xmlns:str="http://exslt.org/strings" 
eudractNumber="2013-004502-26" 
sponsor="Novo Nordisk">
	<trialInformation>
		<sponsorProtocolCode>
			NN9535-3627
		</sponsorProtocolCode>
		<fullTitle>
			The full title
		</fullTitle>
		<isrctnIdentifier xsi:nil="true" />
		<usctnIdentifier>
			NCT02305381
		</usctnIdentifier>
		<whoIdentifier>
			U1111-1149-3738
		</whoIdentifier>
		<partOfPIP>
			false
		</partOfPIP>
		<art45Related>
			false
		</art45Related>
		<art46Related>
			false
		</art46Related>
		<analysisStage>
			<value>
				ANALYSIS_STAGE.final
			</value>
		</analysisStage>
		<analysisStageDate>
			2016-06-29T00:00:00
		</analysisStageDate>
		<analysisForPrimaryCompletion>
			true
		</analysisForPrimaryCompletion>
		<primaryCompletionDate>
			2015-11-21T00:00:00
		</primaryCompletionDate>
		<isGlobalEndOfTrialReached>
			true
		</isGlobalEndOfTrialReached>
		<globalEndOfTrialPremature>
			false
		</globalEndOfTrialPremature>
		<globalEndOfTrialDate>
			2015-11-21T00:00:00
		</globalEndOfTrialDate>
		<mainObjective>
			The primary objective
		</mainObjective>
		<recruitmentStartDate>
			2014-12-01T00:00:00
		</recruitmentStartDate>
		<longTermFollowUpPlanned>
			false
		</longTermFollowUpPlanned>
		<idmcInvolvement>
			true
		</idmcInvolvement>
		<subjectsProtection>
			The trial was conducted in accordance with the Declaration of Helsinki, ICH Good Clinical Practice, EN ISO 14155 Part 1 and 2 and FDA 21 CFR 312.120.
		</subjectsProtection>
		<backgroundTherapy>
			Subjects were to continue pre-trial background medication throughout the entire trial. Basal insulin
			with or without metformin were considered background medication.
		</backgroundTherapy>
		<comparatorEvidence>
			Not applicble
		</comparatorEvidence>
		<sponsors>
			<sponsor>
				<address>
					<postCode>
						2880
					</postCode>
					<streetAddress>
						Novo All√©
					</streetAddress>
					<townCity>
						Bagsvaerd
					</townCity>
					<country>
						<eutctId>
							100000000377
						</eutctId>
						<version>
							1
						</version>
					</country>
				</address>
				<organisationName>
					Novo Nordisk A/S
				</organisationName>
				<publicContact>
					<emailAddress>
						clinicaltrials@novonordisk.com
					</emailAddress>
					<functionalContactName>
						Global Clinical Registry (GCR 1452)
					</functionalContactName>
					<organisationName>
						Novo Nordisk A/S
					</organisationName>
					<telephoneNumber>
						<countryCode />
						<number />
					</telephoneNumber>
				</publicContact>
				<scientificContact>
					<emailAddress>
						clinicaltrials@novonordisk.com
					</emailAddress>
					<functionalContactName>
						Global Clinical Registry (GCR 1452)
					</functionalContactName>
					<organisationName>
						Novo Nordisk A/S
					</organisationName>
					<telephoneNumber>
						<countryCode />
						<number />
					</telephoneNumber>
				</scientificContact>
			</sponsor>
		</sponsors>
		<pipnumbers />
		<otherIdentifiers>
			<otherIdentifier>
				<name>
					Japanese trial registration
				</name>
				<number>
					JapicCTI-142729
				</number>
			</otherIdentifier>
		</otherIdentifiers>
		<countrySubjectCounts>
			<countrySubjectCount>
				<subjects>
					70
				</subjects>
				<country>
					<eutctId>
						100000000403
					</eutctId>
					<version>
						11
					</version>
				</country>
			</countrySubjectCount>
			<countrySubjectCount>
				<subjects>
					61
				</subjects>
				<country>
					<eutctId>
						100000000432
					</eutctId>
					<version>
						11
					</version>
				</country>
			</countrySubjectCount>
			<countrySubjectCount>
				<subjects>
					45
				</subjects>
				<country>
					<eutctId>
						100000000518
					</eutctId>
					<version>
						11
					</version>
				</country>
			</countrySubjectCount>
			<countrySubjectCount>
				<subjects>
					40
				</subjects>
				<country>
					<eutctId>
						100000000523
					</eutctId>
					<version>
						11
					</version>
				</country>
			</countrySubjectCount>
			<countrySubjectCount>
				<subjects>
					180
				</subjects>
				<country>
					<eutctId>
						100000000557
					</eutctId>
					<version>
						11
					</version>
				</country>
			</countrySubjectCount>
		</countrySubjectCounts>
		<populationAgeGroup>
			<inUtero>
				0
			</inUtero>
			<pretermNewbornInfants>
				0
			</pretermNewbornInfants>
			<newborns>
				0
			</newborns>
			<infantsAndToddlers>
				0
			</infantsAndToddlers>
			<children>
				0
			</children>
			<adolescents>
				0
			</adolescents>
			<adults>
				281
			</adults>
			<elderly65To84>
				114
			</elderly65To84>
			<elderlyOver85>
				1
			</elderlyOver85>
		</populationAgeGroup>
	</trialInformation>
	<subjectDisposition>
		<recruitmentDetails>
			The trial was conducted at 90 sites in 5 countries, as follows: Germany: 10 sites; Japan: 6 sites; Serbia: 4 sites; Slovakia: 5 sites; United States: 65.
		</recruitmentDetails>
		<screeningInformation>
			Not applicable
		</screeningInformation>
		<postAssignmentPeriods>
			<postAssignmentPeriod id="_08868639-8cb6-4453-8891-85e5f322cf28">
				<completedMilestone id="_e66acdc5-9fd7-427d-a34e-a31b27a8a788" />
				<startedMilestone id="_3c8e3c9d-1b44-472d-bc1f-e143dad0b528" />
				<otherMilestones>
					<otherMilestone id="_0419f87a-e4aa-4fea-9c38-81a299628ee2">
						<title>
							Premature discontinuation of treatment
						</title>
					</otherMilestone>
				</otherMilestones>
				<title>
					Overall Study
				</title>
				<blindingImplementationDetails>
					Semaglutide and placebo were supplied in similar 1.5 mL pre-filled PDS290 pen-injector and were by all means visually identical and were packed and labelled to fulfil the requirements for double-blind
					procedures. Furthermore, equal volumes of semaglutide and placebo were administered
					during treatment ensuring blinding within dose-level.
				</blindingImplementationDetails>
				<mutuallyExclusiveArms>
					true
				</mutuallyExclusiveArms>
				<baselinePeriod>
					true
				</baselinePeriod>
				<blinded>
					true
				</blinded>
				<clinicalTrialRoles>
					<clinicalTrialRole>
						<value>
							TRIAL_ROLE.subject
						</value>
					</clinicalTrialRole>
					<clinicalTrialRole>
						<value>
							TRIAL_ROLE.investigator
						</value>
					</clinicalTrialRole>
				</clinicalTrialRoles>
				<blindingType>
					<value>
						BLINDING.double
					</value>
				</blindingType>
				<allocation>
					<value>
						ALLOCATION.randControlled
					</value>
				</allocation>
				<arms>
					<arm id="arm1Id">
						<title>
							Semaglutide 0.5 mg
						</title>
						<description>
							Subjects received semaglutide 0.25 mg subcutaneous (sc) injection once weekly for 4 weeks followed by semaglutide 0.5 mg once weekly up to Week 30.
						</description>
						<type>
							<value>
								ARM_TYPE.experimental
							</value>
						</type>
						<armProducts>
							<armProduct>
								<name>
									Semaglutide
								</name>
								<code />
								<otherNames />
								<doseAndAdministrationDetails>
									Semaglutide injection was administered in the thigh, abdomen or upper arm, at any time of day irrespective of meals. The injections were to be administered on the same day of the week during the trial.
								</doseAndAdministrationDetails>
								<pharmaceuticalForms>
									<pharmaceuticalForm>
										<eutctId>
											100000073863
										</eutctId>
										<version>
											12
										</version>
									</pharmaceuticalForm>
								</pharmaceuticalForms>
								<routesOfAdministration>
									<routeOfAdministration>
										<eutctId>
											100000073633
										</eutctId>
										<version>
											4
										</version>
									</routeOfAdministration>
								</routesOfAdministration>
							</armProduct>
						</armProducts>
						<startedMilestoneAchievement startedMilestoneId="_3c8e3c9d-1b44-472d-bc1f-e143dad0b528">
							<comment />
							<subjects>
								132
							</subjects>
						</startedMilestoneAchievement>
						<completedMilestoneAchievement completedMilestoneId="_e66acdc5-9fd7-427d-a34e-a31b27a8a788">
							<comment />
							<subjects>
								127
							</subjects>
						</completedMilestoneAchievement>
						<otherMilestoneAchievements>
							<otherMilestoneAchievement otherMilestoneId="_0419f87a-e4aa-4fea-9c38-81a299628ee2">
								<comment />
								<subjects>
									14
								</subjects>
							</otherMilestoneAchievement>
						</otherMilestoneAchievements>
						<notCompletedReasonDetails>
							<reasonDetail reasonNotCompletedId="_cb00e94e-ca04-4c14-bc2c-84f90ef09247">
								<subjects>
									5
								</subjects>
								<comment />
								<extraInfo />
							</reasonDetail>
						</notCompletedReasonDetails>
						<joinedReasonDetails />
					</arm>
					<arm id="arm2Id">
						<title>
							Semaglutide 1.0 mg
						</title>
						<description>
							Subjects received semaglutide 0.25 mg sc injection once weekly for 4 weeks followed by semaglutide 0.5 mg once weekly for next 4 weeks and then semaglutide 1.0 mg once weekly up to week 30.
						</description>
						<type>
							<value>
								ARM_TYPE.experimental
							</value>
						</type>
						<armProducts>
							<armProduct>
								<name>
									Semaglutide
								</name>
								<code />
								<otherNames />
								<doseAndAdministrationDetails>
									Semaglutide injection was administered in the thigh, abdomen or upper arm, at any time of day irrespective of meals. The injections were to be administered on the same day of the week during the trial.
								</doseAndAdministrationDetails>
								<pharmaceuticalForms>
									<pharmaceuticalForm>
										<eutctId>
											100000073863
										</eutctId>
										<version>
											12
										</version>
									</pharmaceuticalForm>
								</pharmaceuticalForms>
								<routesOfAdministration>
									<routeOfAdministration>
										<eutctId>
											100000073633
										</eutctId>
										<version>
											4
										</version>
									</routeOfAdministration>
								</routesOfAdministration>
							</armProduct>
						</armProducts>
						<startedMilestoneAchievement startedMilestoneId="_3c8e3c9d-1b44-472d-bc1f-e143dad0b528">
							<comment />
							<subjects>
								131
							</subjects>
						</startedMilestoneAchievement>
						<completedMilestoneAchievement completedMilestoneId="_e66acdc5-9fd7-427d-a34e-a31b27a8a788">
							<comment />
							<subjects>
								127
							</subjects>
						</completedMilestoneAchievement>
						<otherMilestoneAchievements>
							<otherMilestoneAchievement otherMilestoneId="_0419f87a-e4aa-4fea-9c38-81a299628ee2">
								<comment />
								<subjects>
									16
								</subjects>
							</otherMilestoneAchievement>
						</otherMilestoneAchievements>
						<notCompletedReasonDetails>
							<reasonDetail reasonNotCompletedId="_cb00e94e-ca04-4c14-bc2c-84f90ef09247">
								<subjects>
									4
								</subjects>
								<comment />
								<extraInfo />
							</reasonDetail>
						</notCompletedReasonDetails>
						<joinedReasonDetails />
					</arm>
					<arm id="arm3Id">
						<title>
							Placebo
						</title>
						<description>
							Subjects received placebo (matched to semaglutide) sc injection once weekly for 30 weeks.
						</description>
						<type>
							<value>
								ARM_TYPE.placeboComp
							</value>
						</type>
						<armProducts>
							<armProduct>
								<name>
									Placebo
								</name>
								<code />
								<otherNames />
								<doseAndAdministrationDetails>
									Placebo injection was administered in the thigh, abdomen or upper arm, at any time of day irrespective of meals. The injections were to be administered on the same day of the week during the trial.
								</doseAndAdministrationDetails>
								<pharmaceuticalForms>
									<pharmaceuticalForm>
										<eutctId>
											100000073863
										</eutctId>
										<version>
											12
										</version>
									</pharmaceuticalForm>
								</pharmaceuticalForms>
								<routesOfAdministration>
									<routeOfAdministration>
										<eutctId>
											100000073633
										</eutctId>
										<version>
											4
										</version>
									</routeOfAdministration>
								</routesOfAdministration>
							</armProduct>
						</armProducts>
						<startedMilestoneAchievement startedMilestoneId="_3c8e3c9d-1b44-472d-bc1f-e143dad0b528">
							<comment />
							<subjects>
								133
							</subjects>
						</startedMilestoneAchievement>
						<completedMilestoneAchievement completedMilestoneId="_e66acdc5-9fd7-427d-a34e-a31b27a8a788">
							<comment />
							<subjects>
								126
							</subjects>
						</completedMilestoneAchievement>
						<otherMilestoneAchievements>
							<otherMilestoneAchievement otherMilestoneId="_0419f87a-e4aa-4fea-9c38-81a299628ee2">
								<comment />
								<subjects>
									13
								</subjects>
							</otherMilestoneAchievement>
						</otherMilestoneAchievements>
						<notCompletedReasonDetails>
							<reasonDetail reasonNotCompletedId="_cb00e94e-ca04-4c14-bc2c-84f90ef09247">
								<subjects>
									7
								</subjects>
								<comment />
								<extraInfo />
							</reasonDetail>
						</notCompletedReasonDetails>
						<joinedReasonDetails />
					</arm>
				</arms>
			</postAssignmentPeriod>
		</postAssignmentPeriods>
		<reasonsNotCompleted>
			<reasonNotCompleted id="_cb00e94e-ca04-4c14-bc2c-84f90ef09247">
				<otherReason>
					Not completed
				</otherReason>
				<type>
					<value>
						NOT_COMPLETED_REASON.other
					</value>
				</type>
			</reasonNotCompleted>
		</reasonsNotCompleted>
		<reasonsJoined />
	</subjectDisposition>
	<baselineCharacteristics>
		<reportingModel>
			<value>
				BASELINE_REPORTING_MODEL.arms
			</value>
		</reportingModel>
		<studyCategoricalCharacteristics />
		<studyContinuousCharacteristics>
			<studyContinuousCharacteristic>
				<readyForValues>
					true
				</readyForValues>
				<title>
					Glycosylated haemoglobin
				</title>
				<description xsi:nil="true" />
				<unit>
					percentage of glycosylated haemoglobin
				</unit>
				<reportingGroups>
					<reportingGroup baselineReportingGroupId="baselineGroup1Id">
						<tendencyValue>
							<value>
								8.36
							</value>
						</tendencyValue>
						<dispersionValue>
							<value>
								0.83
							</value>
							<highRangeValue xsi:nil="true" />
						</dispersionValue>
					</reportingGroup>
					<reportingGroup baselineReportingGroupId="baselineGroup2Id">
						<tendencyValue>
							<value>
								8.31
							</value>
						</tendencyValue>
						<dispersionValue>
							<value>
								0.82
							</value>
							<highRangeValue xsi:nil="true" />
						</dispersionValue>
					</reportingGroup>
					<reportingGroup baselineReportingGroupId="baselineGroup3Id">
						<tendencyValue>
							<value>
								8.42
							</value>
						</tendencyValue>
						<dispersionValue>
							<value>
								0.88
							</value>
							<highRangeValue xsi:nil="true" />
						</dispersionValue>
					</reportingGroup>
				</reportingGroups>
				<subjectAnalysisSets />
				<centralTendencyType>
					<value>
						CENTRAL_TENDENCY.arithmetic
					</value>
				</centralTendencyType>
				<dispersionType>
					<value>
						DISPERSION.standardDeviation
					</value>
				</dispersionType>
			</studyContinuousCharacteristic>
			<studyContinuousCharacteristic>
				<readyForValues>
					true
				</readyForValues>
				<title>
					Body weight
				</title>
				<description xsi:nil="true" />
				<unit>
					kg
				</unit>
				<reportingGroups>
					<reportingGroup baselineReportingGroupId="baselineGroup1Id">
						<tendencyValue>
							<value>
								92.74
							</value>
						</tendencyValue>
						<dispersionValue>
							<value>
								19.57
							</value>
							<highRangeValue xsi:nil="true" />
						</dispersionValue>
					</reportingGroup>
					<reportingGroup baselineReportingGroupId="baselineGroup2Id">
						<tendencyValue>
							<value>
								92.49
							</value>
						</tendencyValue>
						<dispersionValue>
							<value>
								22.23
							</value>
							<highRangeValue xsi:nil="true" />
						</dispersionValue>
					</reportingGroup>
					<reportingGroup baselineReportingGroupId="baselineGroup3Id">
						<tendencyValue>
							<value>
								89.88
							</value>
						</tendencyValue>
						<dispersionValue>
							<value>
								21.06
							</value>
							<highRangeValue xsi:nil="true" />
						</dispersionValue>
					</reportingGroup>
				</reportingGroups>
				<subjectAnalysisSets />
				<centralTendencyType>
					<value>
						CENTRAL_TENDENCY.arithmetic
					</value>
				</centralTendencyType>
				<dispersionType>
					<value>
						DISPERSION.standardDeviation
					</value>
				</dispersionType>
			</studyContinuousCharacteristic>
			<studyContinuousCharacteristic>
				<readyForValues>
					true
				</readyForValues>
				<title>
					Fasting plasma glucose
				</title>
				<description xsi:nil="true" />
				<unit>
					mg/dL
				</unit>
				<reportingGroups>
					<reportingGroup baselineReportingGroupId="baselineGroup1Id">
						<tendencyValue>
							<value>
								161.0
							</value>
						</tendencyValue>
						<dispersionValue>
							<value>
								62.38
							</value>
							<highRangeValue xsi:nil="true" />
						</dispersionValue>
					</reportingGroup>
					<reportingGroup baselineReportingGroupId="baselineGroup2Id">
						<tendencyValue>
							<value>
								152.5
							</value>
						</tendencyValue>
						<dispersionValue>
							<value>
								50.91
							</value>
							<highRangeValue xsi:nil="true" />
						</dispersionValue>
					</reportingGroup>
					<reportingGroup baselineReportingGroupId="baselineGroup3Id">
						<tendencyValue>
							<value>
								154.1
							</value>
						</tendencyValue>
						<dispersionValue>
							<value>
								46.66
							</value>
							<highRangeValue xsi:nil="true" />
						</dispersionValue>
					</reportingGroup>
				</reportingGroups>
				<subjectAnalysisSets />
				<centralTendencyType>
					<value>
						CENTRAL_TENDENCY.arithmetic
					</value>
				</centralTendencyType>
				<dispersionType>
					<value>
						DISPERSION.standardDeviation
					</value>
				</dispersionType>
			</studyContinuousCharacteristic>
			<studyContinuousCharacteristic>
				<readyForValues>
					true
				</readyForValues>
				<title>
					Insulin Dose
				</title>
				<description>
					Number of subjects analysed for this parameter=131, 131 and 133
				</description>
				<unit>
					international unit
				</unit>
				<reportingGroups>
					<reportingGroup baselineReportingGroupId="baselineGroup1Id">
						<tendencyValue>
							<value>
								35.00
							</value>
						</tendencyValue>
						<dispersionValue>
							<value>
								15.00
							</value>
							<highRangeValue>
								300.00
							</highRangeValue>
						</dispersionValue>
					</reportingGroup>
					<reportingGroup baselineReportingGroupId="baselineGroup2Id">
						<tendencyValue>
							<value>
								36.00
							</value>
						</tendencyValue>
						<dispersionValue>
							<value>
								14.00
							</value>
							<highRangeValue>
								320.00
							</highRangeValue>
						</dispersionValue>
					</reportingGroup>
					<reportingGroup baselineReportingGroupId="baselineGroup3Id">
						<tendencyValue>
							<value>
								36.00
							</value>
						</tendencyValue>
						<dispersionValue>
							<value>
								12.00
							</value>
							<highRangeValue>
								124.00
							</highRangeValue>
						</dispersionValue>
					</reportingGroup>
				</reportingGroups>
				<subjectAnalysisSets />
				<centralTendencyType>
					<value>
						CENTRAL_TENDENCY.median
					</value>
				</centralTendencyType>
				<dispersionType>
					<value>
						DISPERSION.fullRange
					</value>
				</dispersionType>
			</studyContinuousCharacteristic>
			<studyContinuousCharacteristic>
				<readyForValues>
					true
				</readyForValues>
				<title>
					Diastolic Blood Pressure
				</title>
				<description xsi:nil="true" />
				<unit>
					mm Hg
				</unit>
				<reportingGroups>
					<reportingGroup baselineReportingGroupId="baselineGroup1Id">
						<tendencyValue>
							<value>
								78.89
							</value>
						</tendencyValue>
						<dispersionValue>
							<value>
								9.72
							</value>
							<highRangeValue xsi:nil="true" />
						</dispersionValue>
					</reportingGroup>
					<reportingGroup baselineReportingGroupId="baselineGroup2Id">
						<tendencyValue>
							<value>
								78.73
							</value>
						</tendencyValue>
						<dispersionValue>
							<value>
								9.98
							</value>
							<highRangeValue xsi:nil="true" />
						</dispersionValue>
					</reportingGroup>
					<reportingGroup baselineReportingGroupId="baselineGroup3Id">
						<tendencyValue>
							<value>
								79.35
							</value>
						</tendencyValue>
						<dispersionValue>
							<value>
								9.71
							</value>
							<highRangeValue xsi:nil="true" />
						</dispersionValue>
					</reportingGroup>
				</reportingGroups>
				<subjectAnalysisSets />
				<centralTendencyType>
					<value>
						CENTRAL_TENDENCY.arithmetic
					</value>
				</centralTendencyType>
				<dispersionType>
					<value>
						DISPERSION.standardDeviation
					</value>
				</dispersionType>
			</studyContinuousCharacteristic>
			<studyContinuousCharacteristic>
				<readyForValues>
					true
				</readyForValues>
				<title>
					Systolic Blood Pressure
				</title>
				<description xsi:nil="true" />
				<unit>
					mm Hg
				</unit>
				<reportingGroups>
					<reportingGroup baselineReportingGroupId="baselineGroup1Id">
						<tendencyValue>
							<value>
								134.87
							</value>
						</tendencyValue>
						<dispersionValue>
							<value>
								15.00
							</value>
							<highRangeValue xsi:nil="true" />
						</dispersionValue>
					</reportingGroup>
					<reportingGroup baselineReportingGroupId="baselineGroup2Id">
						<tendencyValue>
							<value>
								134.40
							</value>
						</tendencyValue>
						<dispersionValue>
							<value>
								16.32
							</value>
							<highRangeValue xsi:nil="true" />
						</dispersionValue>
					</reportingGroup>
					<reportingGroup baselineReportingGroupId="baselineGroup3Id">
						<tendencyValue>
							<value>
								134.99
							</value>
						</tendencyValue>
						<dispersionValue>
							<value>
								16.68
							</value>
							<highRangeValue xsi:nil="true" />
						</dispersionValue>
					</reportingGroup>
				</reportingGroups>
				<subjectAnalysisSets />
				<centralTendencyType>
					<value>
						CENTRAL_TENDENCY.arithmetic
					</value>
				</centralTendencyType>
				<dispersionType>
					<value>
						DISPERSION.standardDeviation
					</value>
				</dispersionType>
			</studyContinuousCharacteristic>
			<studyContinuousCharacteristic>
				<readyForValues>
					true
				</readyForValues>
				<title>
					Diabetes Treatment Satisfaction Questionnaire
				</title>
				<description>
					The DTSQs questionnaire was used to assess subjects‚Äô treatment satisfaction and contained 8 components and evaluates the diabetes treatment (including insulin, tablets and/or diet) in terms of convenience, flexibility and general feelings towards the treatment. The result presented is the 'Treatment Satisfaction' summary score, which is the sum of 6 of the 8 items of the DTSQs questionnaire. Response options range from 6 (best case) to 0 (worst case). Total scores for treatment satisfaction range from 0-36. Higher scores indicate higher satisfaction.
				</description>
				<unit>
					scores on a scale
				</unit>
				<reportingGroups>
					<reportingGroup baselineReportingGroupId="baselineGroup1Id">
						<tendencyValue>
							<value>
								28.86
							</value>
						</tendencyValue>
						<dispersionValue>
							<value>
								6.35
							</value>
							<highRangeValue xsi:nil="true" />
						</dispersionValue>
					</reportingGroup>
					<reportingGroup baselineReportingGroupId="baselineGroup2Id">
						<tendencyValue>
							<value>
								28.62
							</value>
						</tendencyValue>
						<dispersionValue>
							<value>
								6.45
							</value>
							<highRangeValue xsi:nil="true" />
						</dispersionValue>
					</reportingGroup>
					<reportingGroup baselineReportingGroupId="baselineGroup3Id">
						<tendencyValue>
							<value>
								27.54
							</value>
						</tendencyValue>
						<dispersionValue>
							<value>
								6.55
							</value>
							<highRangeValue xsi:nil="true" />
						</dispersionValue>
					</reportingGroup>
				</reportingGroups>
				<subjectAnalysisSets />
				<centralTendencyType>
					<value>
						CENTRAL_TENDENCY.arithmetic
					</value>
				</centralTendencyType>
				<dispersionType>
					<value>
						DISPERSION.standardDeviation
					</value>
				</dispersionType>
			</studyContinuousCharacteristic>
		</studyContinuousCharacteristics>
		<ageContinuousCharacteristic>
			<readyForValues>
				true
			</readyForValues>
			<title>
				Age Continuous
			</title>
			<description xsi:nil="true" />
			<unit>
				years
			</unit>
			<reportingGroups>
				<reportingGroup baselineReportingGroupId="baselineGroup1Id">
					<tendencyValue>
						<value>
							59.1
						</value>
					</tendencyValue>
					<dispersionValue>
						<value>
							10.3
						</value>
						<highRangeValue xsi:nil="true" />
					</dispersionValue>
				</reportingGroup>
				<reportingGroup baselineReportingGroupId="baselineGroup2Id">
					<tendencyValue>
						<value>
							58.5
						</value>
					</tendencyValue>
					<dispersionValue>
						<value>
							9.0
						</value>
						<highRangeValue xsi:nil="true" />
					</dispersionValue>
				</reportingGroup>
				<reportingGroup baselineReportingGroupId="baselineGroup3Id">
					<tendencyValue>
						<value>
							58.8
						</value>
					</tendencyValue>
					<dispersionValue>
						<value>
							10.9
						</value>
						<highRangeValue xsi:nil="true" />
					</dispersionValue>
				</reportingGroup>
			</reportingGroups>
			<subjectAnalysisSets />
			<centralTendencyType>
				<value>
					CENTRAL_TENDENCY.arithmetic
				</value>
			</centralTendencyType>
			<dispersionType>
				<value>
					DISPERSION.standardDeviation
				</value>
			</dispersionType>
		</ageContinuousCharacteristic>
		<genderCategoricalCharacteristic>
			<readyForValues>
				true
			</readyForValues>
			<title>
				Gender Categorical
			</title>
			<description xsi:nil="true" />
			<unit>
				Subjects
			</unit>
			<reportingGroups>
				<reportingGroup baselineReportingGroupId="baselineGroup1Id">
					<countableValues>
						<countableValue categoryId="femaleCategoryId">
							<value>
								58
							</value>
						</countableValue>
						<countableValue categoryId="maleCategoryId">
							<value>
								74
							</value>
						</countableValue>
					</countableValues>
				</reportingGroup>
				<reportingGroup baselineReportingGroupId="baselineGroup2Id">
					<countableValues>
						<countableValue categoryId="femaleCategoryId">
							<value>
								54
							</value>
	read-group-categorical-measurement-values					</countableValue>
						<countableValue categoryId="maleCategoryId">
							<value>
								77
							</value>
						</countableValue>
					</countableValues>
				</reportingGroup>
				<reportingGroup baselineReportingGroupId="baselineGroup3Id">
					<countableValues>
						<countableValue categoryId="femaleCategoryId">
							<value>
								62
							</value>
						</countableValue>
						<countableValue categoryId="maleCategoryId">
							<value>
								71
							</value>
						</countableValue>
					</countableValues>
				</reportingGroup>
			</reportingGroups>
			<subjectAnalysisSets />
			<totalBaselineGroup id="_2e46d761-ddb5-4eb6-aa3e-79011f32d73b">
				<title>
					Total title
				</title>
				<countableValues>
					<countableValue categoryId="femaleCategoryId">
						<value>
							174
						</value>
					</countableValue>
					<countableValue categoryId="maleCategoryId">
						<value>
							222
						</value>
					</countableValue>
				</countableValues>
			</totalBaselineGroup>
			<categories>
				<category id="femaleCategoryId">
					<name>
						Femalecategory
					</name>
				</category>
				<category id="maleCategoryId">
					<name>
						Male
					</name>
				</category>
			</categories>
		</genderCategoricalCharacteristic>
		<ageCategoricalCharacteristic>
			<readyForValues>
				true
			</readyForValues>
			<title>
				Age Categorical
			</title>
			<description xsi:nil="true" />
			<unit>
				Subjects
			</unit>
			<reportingGroups>
				<reportingGroup baselineReportingGroupId="baselineGroup1Id">
					<countableValues>
						<countableValue categoryId="adultsCategoryId">
							<value>
								93
							</value>
						</countableValue>
						<countableValue categoryId="pensionersCategoryId">
							<value>
								39
							</value>
						</countableValue>
						<countableValue categoryId="octogenarianCategoryId">
							<value>
								0
							</value>
						</countableValue>
					</countableValues>
				</reportingGroup>
				<reportingGroup baselineReportingGroupId="baselineGroup2Id">
					<countableValues>
						<countableValue categoryId="adultsCategoryId">
							<value>
								102
							</value>
						</countableValue>
						<countableValue categoryId="pensionersCategoryId">
							<value>
								29
							</value>
						</countableValue>
						<countableValue categoryId="octogenarianCategoryId">
							<value>
								0
							</value>
						</countableValue>
					</countableValues>
				</reportingGroup>
				<reportingGroup baselineReportingGroupId="baselineGroup3Id">
					<countableValues>
						<countableValue categoryId="adultsCategoryId">
							<value>
								86
							</value>
						</countableValue>
						<countableValue categoryId="pensionersCategoryId">
							<value>
								46
							</value>
						</countableValue>
						<countableValue categoryId="octogenarianCategoryId">
							<value>
								1
							</value>
						</countableValue>
					</countableValues>
				</reportingGroup>
			</reportingGroups>
			<subjectAnalysisSets />
			<totalBaselineGroup id="_1d813103-8e97-4a10-84d0-91e0e7f730e9">
				<title>
					Total title
				</title>
				<countableValues>
					<countableValue categoryId="adultsCategoryId">
						<value>
							281
						</value>
					</countableValue>
					<countableValue categoryId="pensionersCategoryId">
						<value>
							114
						</value>
					</countableValue>
					<countableValue categoryId="octogenarianCategoryId">
						<value>
							1
						</value>
					</countableValue>
				</countableValues>
			</totalBaselineGroup>
			<categories>
				<category id="adultsCategoryId">
					<name>
						Adults (18-64 years)
					</name>
				</category>
				<category id="pensionersCategoryId">
					<name>
						From 65-84 years
					</name>
				</category>
				<category id="octogenarianCategoryId">
					<name>
						85 years and over
					</name>
				</category>
			</categories>
		</ageCategoricalCharacteristic>
		<baselineReportingGroups>
			<baselineReportingGroup postAssignmentPeriodId="_08868639-8cb6-4453-8891-85e5f322cf28" armId="arm1Id" id="baselineGroup1Id">
				<subjects>
					132
				</subjects>
				<description>
					Subjects received semaglutide 0.25 mg subcutaneous (sc) injection once weekly for 4 weeks followed by semaglutide 0.5 mg once weekly up to Week 30.
				</description>
			</baselineReportingGroup>
			<baselineReportingGroup postAssignmentPeriodId="_08868639-8cb6-4453-8891-85e5f322cf28" armId="arm2Id" id="baselineGroup2Id">
				<subjects>
					131
				</subjects>
				<description>
					Subjects received semaglutide 0.25 mg sc injection once weekly for 4 weeks followed by semaglutide 0.5 mg once weekly for next 4 weeks and then semaglutide 1.0 mg once weekly up to week 30.
				</description>
			</baselineReportingGroup>
			<baselineReportingGroup postAssignmentPeriodId="_08868639-8cb6-4453-8891-85e5f322cf28" armId="arm3Id" id="baselineGroup3Id">
				<subjects>
					133
				</subjects>
				<description>
					Subjects received placebo (matched to semaglutide) sc injection once weekly for 30 weeks.
				</description>
			</baselineReportingGroup>
		</baselineReportingGroups>
	</baselineCharacteristics>
	<endPoints>
		<endPoint>
			<title>
				Change in HbA1c
			</title>
			<description>
				Estimated mean change from baseline in HbA1c at week 30. The post-baseline responses are analysed using a mixed model for repeated measurements with treatment, country and stratification variable (HbA1c level at screening [&lt;= 8.0% or &gt; 8.0%] crossed with use of metformin [yes or no]; 2 by 2 levels) as fixed factors and baseline value as covariate, all nested within visit. Mean estimates are adjusted according to observed baseline distribution. Missing data was imputed using mixed model for repeated measurements. Analysis was performed on full analysis set which included all randomised subjects who had received at least 1 dose of randomised semaglutide or placebo.
			</description>
			<readyForValues>
				true
			</readyForValues>
			<countable>
				false
			</countable>
			<unit>
				percentage of glycosylated hemoglobin
			</unit>
			<timeFrame>
				From baseline to week 30
			</timeFrame>
			<type>
				<value>
					ENDPOINT_TYPE.primary
				</value>
			</type>
			<centralTendencyType>
				<value>
					MEASURE_TYPE.leastSquares
				</value>
			</centralTendencyType>
			<dispersionType>
				<value>
					ENDPOINT_DISPERSION.standardError
				</value>
			</dispersionType>
			<categories />
			<armReportingGroups>
				<armReportingGroup armId="arm1Id" id="_a1918913-d5cf-4da3-be62-3cd32d66941c">
					<countableValues />
					<tendencyValues>
						<tendencyValue>
							<value>
								-1.45
							</value>
						</tendencyValue>
					</tendencyValues>
					<dispersionValues>
						<dispersionValue>
							<value>
								0.09
							</value>
							<highRangeValue xsi:nil="true" />
						</dispersionValue>
					</dispersionValues>
					<subjects>
						132
					</subjects>
				</armReportingGroup>
				<armReportingGroup armId="arm2Id" id="_ebeac690-06d1-45ed-a480-0969eff67304">
					<countableValues />
					<tendencyValues>
						<tendencyValue>
							<value>
								-1.85
							</value>
						</tendencyValue>
					</tendencyValues>
					<dispersionValues>
						<dispersionValue>
							<value>
								0.09
							</value>
							<highRangeValue xsi:nil="true" />
						</dispersionValue>
					</dispersionValues>
					<subjects>
						131
					</subjects>
				</armReportingGroup>
				<armReportingGroup armId="arm3Id" id="_88ec59ef-6d7f-4316-ba20-eaf6e80b2c47">
					<countableValues />
					<tendencyValues>
						<tendencyValue>
							<value>
								-0.09
							</value>
						</tendencyValue>
					</tendencyValues>
					<dispersionValues>
						<dispersionValue>
							<value>
								0.09
							</value>
							<highRangeValue xsi:nil="true" />
						</dispersionValue>
					</dispersionValues>
					<subjects>
						133
					</subjects>
				</armReportingGroup>
			</armReportingGroups>
			<subjectAnalysisSetReportingGroups />
			<statisticalAnalyses>
				<statisticalAnalysis>
					<title>
						Analysis 1: Semaglutide 1.0 mg vs Placebo
					</title>
					<description>
						Hierarchical testing was performed as per sequence listed below:Change in HbA1c: semaglutide 1.0 mg vs placebo. Change in HbA1c: semaglutide 0.5 mg vs placebo. Change in body weight: semaglutide 1.0 mg vs placebo. Change in body weight: semaglutide 0.5 mg vs placebo. Analysis was performed using MMRM with treatment, country and stratification variable (HbA1c at screening [‚â§8.0% or &gt;8.0%] crossed with use of metformin [yes or no]; 2 by 2 levels) as fixed factors and baseline value as covariate
					</description>
					<type>
						<value>
							ANALYSIS_TYPE.superiority
						</value>
					</type>
					<analysisSpecification>
						<value>
							ANALYSIS_SPEC.preSpecified
						</value>
					</analysisSpecification>
					<comment>
						Superiority for change in HbA1c was claimed if the upper limit of the 2-sided 95% CI for the estimated difference was below 0%
					</comment>
					<statisticalHypothesisTest>
						<method>
							<value>
								HYPOTHESIS_METHOD.mixedModel
							</value>
						</method>
						<value>
							0.0001
						</value>
						<valueEqualityRelation>
							&lt;
						</valueEqualityRelation>
					</statisticalHypothesisTest>
					<parameterEstimate>
						<confidenceInterval>
							<lowerLimit>
								-2.01
							</lowerLimit>
							<percentage>
								95
							</percentage>
							<sides>
								<value>
									CONF_INTERVAL_SIDE.twoSided
								</value>
							</sides>
							<upperLimit>
								-1.50
							</upperLimit>
						</confidenceInterval>
						<effectEstimate />
						<otherType>
							Treatment difference
						</otherType>
						<pointEstimate>
							-1.75
						</pointEstimate>
						<type>
							<value>
								PARAMETER_TYPE.other
							</value>
						</type>
						<variabilityEstimate />
					</parameterEstimate>
					<armComparisonGroupId>
						_ebeac690-06d1-45ed-a480-0969eff67304
					</armComparisonGroupId>
					<armComparisonGroupId>
						_88ec59ef-6d7f-4316-ba20-eaf6e80b2c47
					</armComparisonGroupId>
				</statisticalAnalysis>
				<statisticalAnalysis>
					<title>
						Analysis 2: Semaglutide 1.0 mg vs Placebo
					</title>
					<description>
						Hierarchical testing was performed as per sequence listed below:Change in HbA1c: semaglutide 1.0 mg vs placebo. Change in HbA1c: semaglutide 0.5 mg vs placebo. Change in body weight: semaglutide 1.0 mg vs placebo. Change in body weight: semaglutide 0.5 mg vs placebo. Analysis was performed using MMRM with treatment, country and stratification variable (HbA1c at screening [‚â§8.0% or &gt;8.0%] crossed with use of metformin [yes or no]; 2 by 2 levels) as fixed factors and baseline value as covariate
					</description>
					<type>
						<value>
							ANALYSIS_TYPE.superiority
						</value>
					</type>
					<analysisSpecification>
						<value>
							ANALYSIS_SPEC.preSpecified
						</value>
					</analysisSpecification>
					<comment>
						Superiority for change in HbA1c was claimed if the upper limit of the 2-sided 95% CI for the estimated difference was below 0%.
					</comment>
					<statisticalHypothesisTest>
						<method>
							<value>
								HYPOTHESIS_METHOD.mixedModel
							</value>
						</method>
						<value>
							0.0001
						</value>
						<valueEqualityRelation>
							&lt;
						</valueEqualityRelation>
					</statisticalHypothesisTest>
					<parameterEstimate>
						<confidenceInterval>
							<lowerLimit>
								-1.61
							</lowerLimit>
							<percentage>
								95
							</percentage>
							<sides>
								<value>
									CONF_INTERVAL_SIDE.twoSided
								</value>
							</sides>
							<upperLimit>
								-1.10
							</upperLimit>
						</confidenceInterval>
						<effectEstimate />
						<otherType>
							Treatment difference
						</otherType>
						<pointEstimate>
							-1.35
						</pointEstimate>
						<type>
							<value>
								PARAMETER_TYPE.other
							</value>
						</type>
						<variabilityEstimate />
					</parameterEstimate>
					<armComparisonGroupId>
						_a1918913-d5cf-4da3-be62-3cd32d66941c
					</armComparisonGroupId>
					<armComparisonGroupId>
						_88ec59ef-6d7f-4316-ba20-eaf6e80b2c47
					</armComparisonGroupId>
				</statisticalAnalysis>
			</statisticalAnalyses>
		</endPoint>
		<endPoint>
			<title>
				Change in body weight
			</title>
			<description>
				Estimated mean change from baseline in HbA1c at week 30. The post-baseline responses are analysed using a mixed model for repeated measurements with treatment, country and stratification variable (HbA1c level at screening [&lt;= 8.0% or &gt; 8.0%] crossed with use of metformin [yes or no]; 2 by 2 levels) as fixed factors and baseline value as covariate, all nested within visit. Mean estimates are adjusted according to observed baseline distribution. Missing data was imputed using mixed model for repeated measurements. Analysis was performed on full analysis set.
			</description>
			<readyForValues>
				true
			</readyForValues>
			<countable>
				false
			</countable>
			<unit>
				kg
			</unit>
			<timeFrame>
				From baseline to week 30
			</timeFrame>
			<type>
				<value>
					ENDPOINT_TYPE.secondary
				</value>
			</type>
			<centralTendencyType>
				<value>
					MEASURE_TYPE.leastSquares
				</value>
			</centralTendencyType>
			<dispersionType>
				<value>
					ENDPOINT_DISPERSION.standardError
				</value>
			</dispersionType>
			<categories />
			<armReportingGroups>
				<armReportingGroup armId="arm1Id" id="_9d6dd311-448f-4b00-b499-898ecf1c8a91">
					<countableValues />
					<tendencyValues>
						<tendencyValue>
							<value>
								-3.67
							</value>
						</tendencyValue>
					</tendencyValues>
					<dispersionValues>
						<dispersionValue>
							<value>
								0.36
							</value>
							<highRangeValue xsi:nil="true" />
						</dispersionValue>
					</dispersionValues>
					<subjects>
						132
					</subjects>
				</armReportingGroup>
				<armReportingGroup armId="arm2Id" id="_0fc1f558-2eb7-45ef-8ace-c67b9dc8e148">
					<countableValues />
					<tendencyValues>
						<tendencyValue>
							<value>
								-6.42
							</value>
						</tendencyValue>
					</tendencyValues>
					<dispersionValues>
						<dispersionValue>
							<value>
								0.36
							</value>
							<highRangeValue xsi:nil="true" />
						</dispersionValue>
					</dispersionValues>
					<subjects>
						131
					</subjects>
				</armReportingGroup>
				<armReportingGroup armId="arm3Id" id="_a0b619ce-468a-4c2f-ba08-2e2f457a9fc1">
					<countableValues />
					<tendencyValues>
						<tendencyValue>
							<value>
								-1.36
							</value>
						</tendencyValue>
					</tendencyValues>
					<dispersionValues>
						<dispersionValue>
							<value>
								0.37
							</value>
							<highRangeValue xsi:nil="true" />
						</dispersionValue>
					</dispersionValues>
					<subjects>
						133
					</subjects>
				</armReportingGroup>
			</armReportingGroups>
			<subjectAnalysisSetReportingGroups />
			<statisticalAnalyses />
		</endPoint>
		<endPoint>
			<title>
				Change in fasting plasma glucose (FPG)
			</title>
			<description>
				Estimated mean change from baseline in FPG at week 30. The post-baseline responses are analysed using a mixed model for repeated measurements with treatment, country and stratification variable (HbA1c level at screening [&lt;= 8.0% or &gt; 8.0%] crossed with use of metformin [yes or no]; 2 by 2 levels) as fixed factors and baseline value as covariate, all nested within visit. Mean estimates are adjusted according to observed baseline distribution. Missing data was imputed using mixed model for repeated measurements. Estimated mean change from baseline in FPG at week 30. Analysis was performed on full analysis set.
			</description>
			<readyForValues>
				true
			</readyForValues>
			<countable>
				false
			</countable>
			<unit>
				mg/dL
			</unit>
			<timeFrame>
				From baseline to week 30
			</timeFrame>
			<type>
				<value>
					ENDPOINT_TYPE.secondary
				</value>
			</type>
			<centralTendencyType>
				<value>
					MEASURE_TYPE.leastSquares
				</value>
			</centralTendencyType>
			<dispersionType>
				<value>
					ENDPOINT_DISPERSION.standardError
				</value>
			</dispersionType>
			<categories />
			<armReportingGroups>
				<armReportingGroup armId="arm1Id" id="_9666f5f4-593a-457f-a5b6-2cfd003cbbed">
					<countableValues />
					<tendencyValues>
						<tendencyValue>
							<value>
								-29.14
							</value>
						</tendencyValue>
					</tendencyValues>
					<dispersionValues>
						<dispersionValue>
							<value>
								3.74
							</value>
							<highRangeValue xsi:nil="true" />
						</dispersionValue>
					</dispersionValues>
					<subjects>
						132
					</subjects>
				</armReportingGroup>
				<armReportingGroup armId="arm2Id" id="_b8a174d2-8383-4832-a239-750fdb31c70a">
					<countableValues />
					<tendencyValues>
						<tendencyValue>
							<value>
								-42.38
							</value>
						</tendencyValue>
					</tendencyValues>
					<dispersionValues>
						<dispersionValue>
							<value>
								3.76
							</value>
							<highRangeValue xsi:nil="true" />
						</dispersionValue>
					</dispersionValues>
					<subjects>
						131
					</subjects>
				</armReportingGroup>
				<armReportingGroup armId="arm3Id" id="_fc406484-66e8-44ac-9c50-e927b67480a2">
					<countableValues />
					<tendencyValues>
						<tendencyValue>
							<value>
								-8.51
							</value>
						</tendencyValue>
					</tendencyValues>
					<dispersionValues>
						<dispersionValue>
							<value>
								4.02
							</value>
							<highRangeValue xsi:nil="true" />
						</dispersionValue>
					</dispersionValues>
					<subjects>
						133
					</subjects>
				</armReportingGroup>
			</armReportingGroups>
			<subjectAnalysisSetReportingGroups />
			<statisticalAnalyses />
		</endPoint>
		<endPoint>
			<title>
				Change in insulin dose
			</title>
			<description>
				Estimated mean change from baseline in insulin dose at week 30 was measured in terms of ratio to baseline. Responses at week 30 are analysed using an Analysis of covariance model with treatment, country and stratification variable (HbA1c level at screening [&lt;= 8.0% or &gt; 8.0%] crossed with use of metformin [yes or no]; 2 by 2 levels) as fixed factors and baseline value as covariate. Mean estimates are adjusted according to observed baseline distribution. Missing data was imputed using last observation carried forward. Analysis was performed on full analysis set.
			</description>
			<readyForValues>
				true
			</readyForValues>
			<countable>
				false
			</countable>
			<unit>
				ratio
			</unit>
			<timeFrame>
				From baseline to week 30
			</timeFrame>
			<type>
				<value>
					ENDPOINT_TYPE.secondary
				</value>
			</type>
			<centralTendencyType>
				<value>
					MEASURE_TYPE.leastSquares
				</value>
			</centralTendencyType>
			<dispersionType>
				<value>
					ENDPOINT_DISPERSION.standardError
				</value>
			</dispersionType>
			<categories />
			<armReportingGroups>
				<armReportingGroup armId="arm1Id" id="_fb9a63cf-01fc-4722-9423-000dab31ee1f">
					<countableValues />
					<tendencyValues>
						<tendencyValue>
							<value>
								0.90
							</value>
						</tendencyValue>
					</tendencyValues>
					<dispersionValues>
						<dispersionValue>
							<value>
								0.01
							</value>
							<highRangeValue xsi:nil="true" />
						</dispersionValue>
					</dispersionValues>
					<subjects>
						132
					</subjects>
				</armReportingGroup>
				<armReportingGroup armId="arm2Id" id="_4883be2d-9340-4bec-8232-437c1118f8b9">
					<countableValues />
					<tendencyValues>
						<tendencyValue>
							<value>
								0.85
							</value>
						</tendencyValue>
					</tendencyValues>
					<dispersionValues>
						<dispersionValue>
							<value>
								0.01
							</value>
							<highRangeValue xsi:nil="true" />
						</dispersionValue>
					</dispersionValues>
					<subjects>
						131
					</subjects>
				</armReportingGroup>
				<armReportingGroup armId="arm3Id" id="_7ea08ecf-0c15-4e58-82e9-d6a3a648c033">
					<countableValues />
					<tendencyValues>
						<tendencyValue>
							<value>
								0.96
							</value>
						</tendencyValue>
					</tendencyValues>
					<dispersionValues>
						<dispersionValue>
							<value>
								0.01
							</value>
							<highRangeValue xsi:nil="true" />
						</dispersionValue>
					</dispersionValues>
					<subjects>
						133
					</subjects>
				</armReportingGroup>
			</armReportingGroups>
			<subjectAnalysisSetReportingGroups />
			<statisticalAnalyses />
		</endPoint>
		<endPoint>
			<title>
				Change in systolic and diastolic blood pressure
			</title>
			<description>
				Estimated mean change from baseline in systolic and diastolic blood pressure at week 30. The post-baseline responses are analysed using a mixed model for repeated measurements with treatment, country and stratification variable (HbA1c level at screening [&lt;= 8.0% or &gt; 8.0%] crossed with use of metformin [yes or no]; 2 by 2 levels) as fixed factors and baseline value as covariate, all nested within visit. Mean estimates are adjusted according to observed baseline distribution. Missing data was imputed using mixed model for repeated measurements. Analysis was performed on full analysis set.
			</description>
			<readyForValues>
				true
			</readyForValues>
			<countable>
				false
			</countable>
			<unit>
				mm Hg
			</unit>
			<timeFrame>
				From baseline to week 30
			</timeFrame>
			<type>
				<value>
					ENDPOINT_TYPE.secondary
				</value>
			</type>
			<centralTendencyType>
				<value>
					MEASURE_TYPE.leastSquares
				</value>
			</centralTendencyType>
			<dispersionType>
				<value>
					ENDPOINT_DISPERSION.standardError
				</value>
			</dispersionType>
			<categories>
				<category id="diastolicCategoryId">
					<name>
						Diastolic blood pressure
					</name>
				</category>
				<category id="systolicCategoryId">
					<name>
						Systolic blood pressure
					</name>
				</category>
			</categories>
			<armReportingGroups>
				<armReportingGroup armId="arm1Id" id="_89ac6bd3-48fa-4b55-939d-acbaaab6db2f">
					<countableValues />
					<tendencyValues>
						<tendencyValue categoryId="diastolicCategoryId">
							<value>
								-1.84
							</value>
						</tendencyValue>
						<tendencyValue categoryId="systolicCategoryId">
							<value>
								-4.29
							</value>
						</tendencyValue>
					</tendencyValues>
					<dispersionValues>
						<dispersionValue categoryId="diastolicCategoryId">
							<value>
								0.73
							</value>
							<highRangeValue xsi:nil="true" />
						</dispersionValue>
						<dispersionValue categoryId="systolicCategoryId">
							<value>
								1.26
							</value>
							<highRangeValue xsi:nil="true" />
						</dispersionValue>
					</dispersionValues>
					<subjects>
						132
					</subjects>
				</armReportingGroup>
				<armReportingGroup armId="arm2Id" id="_3a75fa90-587b-4b80-9a4c-348177ce2825">
					<countableValues />
					<tendencyValues>
						<tendencyValue categoryId="diastolicCategoryId">
							<value>
								-1.50
							</value>
						</tendencyValue>
						<tendencyValue categoryId="systolicCategoryId">
							<value>
								-7.27
							</value>
						</tendencyValue>
					</tendencyValues>
					<dispersionValues>
						<dispersionValue categoryId="diastolicCategoryId">
							<value>
								0.74
							</value>
							<highRangeValue xsi:nil="true" />
						</dispersionValue>
						<dispersionValue categoryId="systolicCategoryId">
							<value>
								1.27
							</value>
							<highRangeValue xsi:nil="true" />
						</dispersionValue>
					</dispersionValues>
					<subjects>
						131
					</subjects>
				</armReportingGroup>
				<armReportingGroup armId="arm3Id" id="_c65c22d6-362d-47de-87d4-7c6ce3debf62">
					<countableValues />
					<tendencyValues>
						<tendencyValue categoryId="diastolicCategoryId">
							<value>
								-2.17
							</value>
						</tendencyValue>
						<tendencyValue categoryId="systolicCategoryId">
							<value>
								-0.99
							</value>
						</tendencyValue>
					</tendencyValues>
					<dispersionValues>
						<dispersionValue categoryId="diastolicCategoryId">
							<value>
								0.79
							</value>
							<highRangeValue xsi:nil="true" />
						</dispersionValue>
						<dispersionValue categoryId="systolicCategoryId">
							<value>
								1.34
							</value>
							<highRangeValue xsi:nil="true" />
						</dispersionValue>
					</dispersionValues>
					<subjects>
						133
					</subjects>
				</armReportingGroup>
			</armReportingGroups>
			<subjectAnalysisSetReportingGroups />
			<statisticalAnalyses />
		</endPoint>
		<endPoint>
			<title>
				Change in patient reported outcomes, Diabetes Treatment Satisfaction Questionnaire (DTSQ)
			</title>
			<description>
				The DTSQs questionnaire was used to assess subjects‚Äô treatment satisfaction and contained 8 components and evaluates the diabetes treatment (including insulin, tablets and/or diet) in terms of convenience, flexibility and general feelings towards the treatment. The result presented is the 'Treatment Satisfaction' summary score, which is the sum of 6 of the 8 items of the DTSQs questionnaire. Response options range from 6 (best case) to 0 (worst case). Total scores for treatment satisfaction range from 0-36. Higher scores indicate higher satisfaction. The post-baseline responses are analysed using an ANCOVA model with treatment, country and stratification variables (HbA1c level at screening [&lt;= 8.0% or &gt; 8.0%] and use of metformin [yes or no]) as fixed factors and baseline value as covariate. Mean estimates are adjusted according to observed baseline distribution. Missing data was imputed using last observation carried forward. Analysis was performed on full analysis set.
			</description>
			<readyForValues>
				true
			</readyForValues>
			<countable>
				false
			</countable>
			<unit>
				Scores on a scale
			</unit>
			<timeFrame>
				From baseline to week 30
			</timeFrame>
			<type>
				<value>
					ENDPOINT_TYPE.secondary
				</value>
			</type>
			<centralTendencyType>
				<value>
					MEASURE_TYPE.leastSquares
				</value>
			</centralTendencyType>
			<dispersionType>
				<value>
					ENDPOINT_DISPERSION.standardError
				</value>
			</dispersionType>
			<categories />
			<armReportingGroups>
				<armReportingGroup armId="arm1Id" id="_8d7a55bc-11e8-4f73-9e12-c9d42d145ebd">
					<countableValues />
					<tendencyValues>
						<tendencyValue>
							<value>
								2.73
							</value>
						</tendencyValue>
					</tendencyValues>
					<dispersionValues>
						<dispersionValue>
							<value>
								0.46
							</value>
							<highRangeValue xsi:nil="true" />
						</dispersionValue>
					</dispersionValues>
					<subjects>
						132
					</subjects>
				</armReportingGroup>
				<armReportingGroup armId="arm2Id" id="_325a874a-5195-407d-972d-b13cfaaaeb3b">
					<countableValues />
					<tendencyValues>
						<tendencyValue>
							<value>
								3.47
							</value>
						</tendencyValue>
					</tendencyValues>
					<dispersionValues>
						<dispersionValue>
							<value>
								0.46
							</value>
							<highRangeValue xsi:nil="true" />
						</dispersionValue>
					</dispersionValues>
					<subjects>
						131
					</subjects>
				</armReportingGroup>
				<armReportingGroup armId="arm3Id" id="_33d94988-77f4-4f2c-8cfd-e704b04d1ae9">
					<countableValues />
					<tendencyValues>
						<tendencyValue>
							<value>
								1.25
							</value>
						</tendencyValue>
					</tendencyValues>
					<dispersionValues>
						<dispersionValue>
							<value>
								0.50
							</value>
							<highRangeValue xsi:nil="true" />
						</dispersionValue>
					</dispersionValues>
					<subjects>
						133
					</subjects>
				</armReportingGroup>
			</armReportingGroups>
			<subjectAnalysisSetReportingGroups />
			<statisticalAnalyses />
		</endPoint>
		<endPoint>
			<title>
				HbA1c below 7.0%
			</title>
			<description>
				Percentage of subjects with HbA1C below 7.0%
			</description>
			<readyForValues>
				true
			</readyForValues>
			<countable>
				false
			</countable>
			<unit>
				percentage of subjects
			</unit>
			<timeFrame>
				After 30 weeks treatment
			</timeFrame>
			<type>
				<value>
					ENDPOINT_TYPE.secondary
				</value>
			</type>
			<centralTendencyType>
				<value>
					MEASURE_TYPE.number
				</value>
			</centralTendencyType>
			<dispersionType>
				<value>
					ENDPOINT_DISPERSION.na
				</value>
			</dispersionType>
			<categories />
			<armReportingGroups>
				<armReportingGroup armId="arm1Id" id="_2b84764c-8f3c-4813-941f-ce847d7b3672">
					<countableValues />
					<tendencyValues>
						<tendencyValue>
							<value>
								60.6
							</value>
						</tendencyValue>
					</tendencyValues>
					<dispersionValues>
						<dispersionValue>
							<value xsi:nil="true" />
							<highRangeValue xsi:nil="true" />
						</dispersionValue>
					</dispersionValues>
					<subjects>
						132
					</subjects>
				</armReportingGroup>
				<armReportingGroup armId="arm2Id" id="_944efbc1-87f5-42b6-b38c-bd87498e4aa0">
					<countableValues />
					<tendencyValues>
						<tendencyValue>
							<value>
								78.6
							</value>
						</tendencyValue>
					</tendencyValues>
					<dispersionValues>
						<dispersionValue>
							<value xsi:nil="true" />
							<highRangeValue xsi:nil="true" />
						</dispersionValue>
					</dispersionValues>
					<subjects>
						131
					</subjects>
				</armReportingGroup>
				<armReportingGroup armId="arm3Id" id="_da02bb1d-0aaa-440f-b7f6-60d7ea06227e">
					<countableValues />
					<tendencyValues>
						<tendencyValue>
							<value>
								10.5
							</value>
						</tendencyValue>
					</tendencyValues>
					<dispersionValues>
						<dispersionValue>
							<value xsi:nil="true" />
							<highRangeValue xsi:nil="true" />
						</dispersionValue>
					</dispersionValues>
					<subjects>
						133
					</subjects>
				</armReportingGroup>
			</armReportingGroups>
			<subjectAnalysisSetReportingGroups />
			<statisticalAnalyses />
		</endPoint>
		<endPoint>
			<title>
				HbA1c below or equal to 6.5% (48 mmol/mol) American Association of Clinical Endocrinologists (AACE) target
			</title>
			<description>
				Percentage of subjects with HbA1C below 7.0% after 30 weeks treatment. Missing data imputed from a mixed model for repeated measurements with treatment, country and stratification variable (HbA1c level at screening [&lt;= 8.0% or &gt; 8.0%] crossed with use of metformin [yes or no]; 2 by 2 levels) as fixed factors and baseline value as covariate, all nested within visit. Analysis was performed on full analysis set.
			</description>
			<readyForValues>
				true
			</readyForValues>
			<countable>
				false
			</countable>
			<unit>
				percentage of participants
			</unit>
			<timeFrame>
				After 30 weeks of treatment
			</timeFrame>
			<type>
				<value>
					ENDPOINT_TYPE.secondary
				</value>
			</type>
			<centralTendencyType>
				<value>
					MEASURE_TYPE.number
				</value>
			</centralTendencyType>
			<dispersionType>
				<value>
					ENDPOINT_DISPERSION.na
				</value>
			</dispersionType>
			<categories />
			<armReportingGroups>
				<armReportingGroup armId="arm1Id" id="_eb96c9e5-16f5-45b8-b19b-9eb477331bc5">
					<countableValues />
					<tendencyValues>
						<tendencyValue>
							<value>
								40.9
							</value>
						</tendencyValue>
					</tendencyValues>
					<dispersionValues>
						<dispersionValue>
							<value xsi:nil="true" />
							<highRangeValue xsi:nil="true" />
						</dispersionValue>
					</dispersionValues>
					<subjects>
						132
					</subjects>
				</armReportingGroup>
				<armReportingGroup armId="arm2Id" id="_19a45836-9a66-476d-9a25-2767930a4f41">
					<countableValues />
					<tendencyValues>
						<tendencyValue>
							<value>
								61.1
							</value>
						</tendencyValue>
					</tendencyValues>
					<dispersionValues>
						<dispersionValue>
							<value xsi:nil="true" />
							<highRangeValue xsi:nil="true" />
						</dispersionValue>
					</dispersionValues>
					<subjects>
						131
					</subjects>
				</armReportingGroup>
				<armReportingGroup armId="arm3Id" id="_360fb526-ae5e-43f1-8211-a87ead2c5ad8">
					<countableValues />
					<tendencyValues>
						<tendencyValue>
							<value>
								4.5
							</value>
						</tendencyValue>
					</tendencyValues>
					<dispersionValues>
						<dispersionValue>
							<value xsi:nil="true" />
							<highRangeValue xsi:nil="true" />
						</dispersionValue>
					</dispersionValues>
					<subjects>
						133
					</subjects>
				</armReportingGroup>
			</armReportingGroups>
			<subjectAnalysisSetReportingGroups />
			<statisticalAnalyses />
		</endPoint>
	</endPoints>
	<trialChanges>
		<globalInterruptions />
		<globalAmendments>
			<globalAmendment>
				<date>
					2015-01-20T00:00:00
				</date>
				<description>
					Change and clarify the wording of "Rescue criteria".
				</description>
			</globalAmendment>
		</globalAmendments>
		<hasGlobalInterruptions>
			false
		</hasGlobalInterruptions>
		<hasGlobalAmendments>
			true
		</hasGlobalAmendments>
		<pubMedReferenceNumbers />
	</trialChanges>
	<subjectAnalysisSets />
	<adverseEvents>
		<description>
			A treatment-emergent adverse event (TEAE) was defined as an AE that had onset date (or increased in severity) during the ‚Äòon-treatment‚Äô observation period.
		</description>
		<nonSeriousEventFrequencyThreshold>
			5
		</nonSeriousEventFrequencyThreshold>
		<timeFrame>
			From the first dose of trial product until the end of the post-treatment follow-up period.The follow-up visit was scheduled to take place 5 weeks after the date of last dose of trial product with a visit window of +7 days (maximum 36 weeks).
		</timeFrame>
		<assessmentMethod>
			<value>
				ADV_EVT_ASSESS_TYPE.systematic
			</value>
		</assessmentMethod>
		<dictionary>
			<otherName xsi:nil="true" />
			<version>
				18.0
			</version>
			<name>
				<value>
					ADV_EVT_DICTIONARY_NAME.meddra
				</value>
			</name>
		</dictionary>
		<reportingGroups>
			<reportingGroup id="ReportingGroup-1">
				<title>
					Semaglutide 0.5 mg
				</title>
				<description>
					Subjects received semaglutide 0.25 mg sc injection once weekly for 4 weeks followed by semaglutide 0.5 mg once weekly up to Week 30.
				</description>
				<subjectsAffectedByNonSeriousAdverseEvents>
					52
				</subjectsAffectedByNonSeriousAdverseEvents>
				<subjectsAffectedBySeriousAdverseEvents>
					8
				</subjectsAffectedBySeriousAdverseEvents>
				<subjectsExposed>
					132
				</subjectsExposed>
				<deathsAllCauses>
					0
				</deathsAllCauses>
				<deathsResultingFromAdverseEvents>
					0
				</deathsResultingFromAdverseEvents>
			</reportingGroup>
			<reportingGroup id="ReportingGroup-2">
				<title>
					Semaglutide 1.0 mg
				</title>
				<description>
					Subjects received semaglutide 0.25 mg sc injection once weekly for 4 weeks followed by semaglutide 0.5 mg once weekly for next 4 weeks and then semaglutide 1.0 mg once weekly up to week 30.
				</description>
				<subjectsAffectedByNonSeriousAdverseEvents>
					54
				</subjectsAffectedByNonSeriousAdverseEvents>
				<subjectsAffectedBySeriousAdverseEvents>
					12
				</subjectsAffectedBySeriousAdverseEvents>
				<subjectsExposed>
					131
				</subjectsExposed>
				<deathsAllCauses>
					0
				</deathsAllCauses>
				<deathsResultingFromAdverseEvents>
					0
				</deathsResultingFromAdverseEvents>
			</reportingGroup>
			<reportingGroup id="ReportingGroup-3">
				<title>
					Placebo
				</title>
				<description>
					Subjects received placebo (matched to semaglutide) sc injection once weekly for 30 weeks.
				</description>
				<subjectsAffectedByNonSeriousAdverseEvents>
					34
				</subjectsAffectedByNonSeriousAdverseEvents>
				<subjectsAffectedBySeriousAdverseEvents>
					9
				</subjectsAffectedBySeriousAdverseEvents>
				<subjectsExposed>
					133
				</subjectsExposed>
				<deathsAllCauses>
					0
				</deathsAllCauses>
				<deathsResultingFromAdverseEvents>
					0
				</deathsResultingFromAdverseEvents>
			</reportingGroup>
		</reportingGroups>
		<nonSeriousAdverseEvents>
			<nonSeriousAdverseEvent>
				<term>
					Decreased appetite
				</term>
				<organSystem>
					<eutctId>
						100000004861
					</eutctId>
					<version>
						18
					</version>
				</organSystem>
				<assessmentMethod>
					<value>
						ADV_EVT_ASSESS_TYPE.systematic
					</value>
				</assessmentMethod>
				<dictionaryOverridden>
					false
				</dictionaryOverridden>
				<values>
					<value reportingGroupId="ReportingGroup-1">
						<occurrences>
							5
						</occurrences>
						<subjectsAffected>
							5
						</subjectsAffected>
						<subjectsExposed>
							132
						</subjectsExposed>
					</value>
					<value reportingGroupId="ReportingGroup-2">
						<occurrences>
							7
						</occurrences>
						<subjectsAffected>
							7
						</subjectsAffected>
						<subjectsExposed>
							131
						</subjectsExposed>
					</value>
					<value reportingGroupId="ReportingGroup-3">
						<occurrences>
							1
						</occurrences>
						<subjectsAffected>
							1
						</subjectsAffected>
						<subjectsExposed>
							133
						</subjectsExposed>
					</value>
				</values>
			</nonSeriousAdverseEvent>
			<nonSeriousAdverseEvent>
				<term>
					Diarrhoea
				</term>
				<organSystem>
					<eutctId>
						100000004856
					</eutctId>
					<version>
						18
					</version>
				</organSystem>
				<assessmentMethod>
					<value>
						ADV_EVT_ASSESS_TYPE.systematic
					</value>
				</assessmentMethod>
				<dictionaryOverridden>
					false
				</dictionaryOverridden>
				<values>
					<value reportingGroupId="ReportingGroup-1">
						<occurrences>
							6
						</occurrences>
						<subjectsAffected>
							6
						</subjectsAffected>
						<subjectsExposed>
							132
						</subjectsExposed>
					</value>
					<value reportingGroupId="ReportingGroup-2">
						<occurrences>
							9
						</occurrences>
						<subjectsAffected>
							9
						</subjectsAffected>
						<subjectsExposed>
							131
						</subjectsExposed>
					</value>
					<value reportingGroupId="ReportingGroup-3">
						<occurrences>
							2
						</occurrences>
						<subjectsAffected>
							2
						</subjectsAffected>
						<subjectsExposed>
							133
						</subjectsExposed>
					</value>
				</values>
			</nonSeriousAdverseEvent>
			<nonSeriousAdverseEvent>
				<term>
					Lipase increased
				</term>
				<organSystem>
					<eutctId>
						100000004848
					</eutctId>
					<version>
						18
					</version>
				</organSystem>
				<assessmentMethod>
					<value>
						ADV_EVT_ASSESS_TYPE.systematic
					</value>
				</assessmentMethod>
				<dictionaryOverridden>
					false
				</dictionaryOverridden>
				<values>
					<value reportingGroupId="ReportingGroup-1">
						<occurrences>
							15
						</occurrences>
						<subjectsAffected>
							12
						</subjectsAffected>
						<subjectsExposed>
							132
						</subjectsExposed>
					</value>
					<value reportingGroupId="ReportingGroup-2">
						<occurrences>
							7
						</occurrences>
						<subjectsAffected>
							7
						</subjectsAffected>
						<subjectsExposed>
							131
						</subjectsExposed>
					</value>
					<value reportingGroupId="ReportingGroup-3">
						<occurrences>
							4
						</occurrences>
						<subjectsAffected>
							4
						</subjectsAffected>
						<subjectsExposed>
							133
						</subjectsExposed>
					</value>
				</values>
			</nonSeriousAdverseEvent>
			<nonSeriousAdverseEvent>
				<term>
					Nasopharyngitis
				</term>
				<organSystem>
					<eutctId>
						100000004862
					</eutctId>
					<version>
						18
					</version>
				</organSystem>
				<assessmentMethod>
					<value>
						ADV_EVT_ASSESS_TYPE.systematic
					</value>
				</assessmentMethod>
				<dictionaryOverridden>
					false
				</dictionaryOverridden>
				<values>
					<value reportingGroupId="ReportingGroup-1">
						<occurrences>
							14
						</occurrences>
						<subjectsAffected>
							11
						</subjectsAffected>
						<subjectsExposed>
							132
						</subjectsExposed>
					</value>
					<value reportingGroupId="ReportingGroup-2">
						<occurrences>
							6
						</occurrences>
						<subjectsAffected>
							6
						</subjectsAffected>
						<subjectsExposed>
							131
						</subjectsExposed>
					</value>
					<value reportingGroupId="ReportingGroup-3">
						<occurrences>
							16
						</occurrences>
						<subjectsAffected>
							14
						</subjectsAffected>
						<subjectsExposed>
							133
						</subjectsExposed>
					</value>
				</values>
			</nonSeriousAdverseEvent>
			<nonSeriousAdverseEvent>
				<term>
					Nausea
				</term>
				<organSystem>
					<eutctId>
						100000004856
					</eutctId>
					<version>
						18
					</version>
				</organSystem>
				<assessmentMethod>
					<value>
						ADV_EVT_ASSESS_TYPE.systematic
					</value>
				</assessmentMethod>
				<dictionaryOverridden>
					false
				</dictionaryOverridden>
				<values>
					<value reportingGroupId="ReportingGroup-1">
						<occurrences>
							21
						</occurrences>
						<subjectsAffected>
							15
						</subjectsAffected>
						<subjectsExposed>
							132
						</subjectsExposed>
					</value>
					<value reportingGroupId="ReportingGroup-2">
						<occurrences>
							23
						</occurrences>
						<subjectsAffected>
							22
						</subjectsAffected>
						<subjectsExposed>
							131
						</subjectsExposed>
					</value>
					<value reportingGroupId="ReportingGroup-3">
						<occurrences>
							6
						</occurrences>
						<subjectsAffected>
							6
						</subjectsAffected>
						<subjectsExposed>
							133
						</subjectsExposed>
					</value>
				</values>
			</nonSeriousAdverseEvent>
			<nonSeriousAdverseEvent>
				<term>
					Upper respiratory tract infection
				</term>
				<organSystem>
					<eutctId>
						100000004862
					</eutctId>
					<version>
						18
					</version>
				</organSystem>
				<assessmentMethod>
					<value>
						ADV_EVT_ASSESS_TYPE.systematic
					</value>
				</assessmentMethod>
				<dictionaryOverridden>
					false
				</dictionaryOverridden>
				<values>
					<value reportingGroupId="ReportingGroup-1">
						<occurrences>
							10
						</occurrences>
						<subjectsAffected>
							8
						</subjectsAffected>
						<subjectsExposed>
							132
						</subjectsExposed>
					</value>
					<value reportingGroupId="ReportingGroup-2">
						<occurrences>
							1
						</occurrences>
						<subjectsAffected>
							1
						</subjectsAffected>
						<subjectsExposed>
							131
						</subjectsExposed>
					</value>
					<value reportingGroupId="ReportingGroup-3">
						<occurrences>
							4
						</occurrences>
						<subjectsAffected>
							4
						</subjectsAffected>
						<subjectsExposed>
							133
						</subjectsExposed>
					</value>
				</values>
			</nonSeriousAdverseEvent>
			<nonSeriousAdverseEvent>
				<term>
					Urinary tract infection
				</term>
				<organSystem>
					<eutctId>
						100000004862
					</eutctId>
					<version>
						18
					</version>
				</organSystem>
				<assessmentMethod>
					<value>
						ADV_EVT_ASSESS_TYPE.systematic
					</value>
				</assessmentMethod>
				<dictionaryOverridden>
					false
				</dictionaryOverridden>
				<values>
					<value reportingGroupId="ReportingGroup-1">
						<occurrences>
							3
						</occurrences>
						<subjectsAffected>
							2
						</subjectsAffected>
						<subjectsExposed>
							132
						</subjectsExposed>
					</value>
					<value reportingGroupId="ReportingGroup-2">
						<occurrences>
							5
						</occurrences>
						<subjectsAffected>
							4
						</subjectsAffected>
						<subjectsExposed>
							131
						</subjectsExposed>
					</value>
					<value reportingGroupId="ReportingGroup-3">
						<occurrences>
							11
						</occurrences>
						<subjectsAffected>
							8
						</subjectsAffected>
						<subjectsExposed>
							133
						</subjectsExposed>
					</value>
				</values>
			</nonSeriousAdverseEvent>
			<nonSeriousAdverseEvent>
				<term>
					Vomiting
				</term>
				<organSystem>
					<eutctId>
						100000004856
					</eutctId>
					<version>
						18
					</version>
				</organSystem>
				<assessmentMethod>
					<value>
						ADV_EVT_ASSESS_TYPE.systematic
					</value>
				</assessmentMethod>
				<dictionaryOverridden>
					false
				</dictionaryOverridden>
				<values>
					<value reportingGroupId="ReportingGroup-1">
						<occurrences>
							9
						</occurrences>
						<subjectsAffected>
							8
						</subjectsAffected>
						<subjectsExposed>
							132
						</subjectsExposed>
					</value>
					<value reportingGroupId="ReportingGroup-2">
						<occurrences>
							17
						</occurrences>
						<subjectsAffected>
							15
						</subjectsAffected>
						<subjectsExposed>
							131
						</subjectsExposed>
					</value>
					<value reportingGroupId="ReportingGroup-3">
						<occurrences>
							4
						</occurrences>
						<subjectsAffected>
							4
						</subjectsAffected>
						<subjectsExposed>
							133
						</subjectsExposed>
					</value>
				</values>
			</nonSeriousAdverseEvent>
		</nonSeriousAdverseEvents>
		<seriousAdverseEvents>
			<seriousAdverseEvent>
				<term>
					Acute coronary syndrome
				</term>
				<organSystem>
					<eutctId>
						100000004849
					</eutctId>
					<version>
						18
					</version>
				</organSystem>
				<assessmentMethod>
					<value>
						ADV_EVT_ASSESS_TYPE.systematic
					</value>
				</assessmentMethod>
				<dictionaryOverridden>
					false
				</dictionaryOverridden>
				<values>
					<value reportingGroupId="ReportingGroup-1">
						<occurrences>
							1
						</occurrences>
						<subjectsAffected>
							1
						</subjectsAffected>
						<subjectsExposed>
							132
						</subjectsExposed>
						<occurrencesCausallyRelatedToTreatment>
							0
						</occurrencesCausallyRelatedToTreatment>
						<fatalities>
							<deaths>
								0
							</deaths>
							<deathsCausallyRelatedToTreatment>
								0
							</deathsCausallyRelatedToTreatment>
						</fatalities>
					</value>
					<value reportingGroupId="ReportingGroup-2">
						<occurrences>
							0
						</occurrences>
						<subjectsAffected>
							0
						</subjectsAffected>
						<subjectsExposed>
							131
						</subjectsExposed>
						<occurrencesCausallyRelatedToTreatment>
							0
						</occurrencesCausallyRelatedToTreatment>
						<fatalities>
							<deaths>
								0
							</deaths>
							<deathsCausallyRelatedToTreatment>
								0
							</deathsCausallyRelatedToTreatment>
						</fatalities>
					</value>
					<value reportingGroupId="ReportingGroup-3">
						<occurrences>
							0
						</occurrences>
						<subjectsAffected>
							0
						</subjectsAffected>
						<subjectsExposed>
							133
						</subjectsExposed>
						<occurrencesCausallyRelatedToTreatment>
							0
						</occurrencesCausallyRelatedToTreatment>
						<fatalities>
							<deaths>
								0
							</deaths>
							<deathsCausallyRelatedToTreatment>
								0
							</deathsCausallyRelatedToTreatment>
						</fatalities>
					</value>
				</values>
			</seriousAdverseEvent>
			<seriousAdverseEvent>
				<term>
					Anaemia
				</term>
				<organSystem>
					<eutctId>
						100000004851
					</eutctId>
					<version>
						18
					</version>
				</organSystem>
				<assessmentMethod>
					<value>
						ADV_EVT_ASSESS_TYPE.systematic
					</value>
				</assessmentMethod>
				<dictionaryOverridden>
					false
				</dictionaryOverridden>
				<values>
					<value reportingGroupId="ReportingGroup-1">
						<occurrences>
							0
						</occurrences>
						<subjectsAffected>
							0
						</subjectsAffected>
						<subjectsExposed>
							132
						</subjectsExposed>
						<occurrencesCausallyRelatedToTreatment>
							0
						</occurrencesCausallyRelatedToTreatment>
						<fatalities>
							<deaths>
								0
							</deaths>
							<deathsCausallyRelatedToTreatment>
								0
							</deathsCausallyRelatedToTreatment>
						</fatalities>
					</value>
					<value reportingGroupId="ReportingGroup-2">
						<occurrences>
							0
						</occurrences>
						<subjectsAffected>
							0
						</subjectsAffected>
						<subjectsExposed>
							131
						</subjectsExposed>
						<occurrencesCausallyRelatedToTreatment>
							0
						</occurrencesCausallyRelatedToTreatment>
						<fatalities>
							<deaths>
								0
							</deaths>
							<deathsCausallyRelatedToTreatment>
								0
							</deathsCausallyRelatedToTreatment>
						</fatalities>
					</value>
					<value reportingGroupId="ReportingGroup-3">
						<occurrences>
							1
						</occurrences>
						<subjectsAffected>
							1
						</subjectsAffected>
						<subjectsExposed>
							133
						</subjectsExposed>
						<occurrencesCausallyRelatedToTreatment>
							0
						</occurrencesCausallyRelatedToTreatment>
						<fatalities>
							<deaths>
								0
							</deaths>
							<deathsCausallyRelatedToTreatment>
								0
							</deathsCausallyRelatedToTreatment>
						</fatalities>
					</value>
				</values>
			</seriousAdverseEvent>
			<seriousAdverseEvent>
				<term>
					Back pain
				</term>
				<organSystem>
					<eutctId>
						100000004859
					</eutctId>
					<version>
						18
					</version>
				</organSystem>
				<assessmentMethod>
					<value>
						ADV_EVT_ASSESS_TYPE.systematic
					</value>
				</assessmentMethod>
				<dictionaryOverridden>
					false
				</dictionaryOverridden>
				<values>
					<value reportingGroupId="ReportingGroup-1">
						<occurrences>
							0
						</occurrences>
						<subjectsAffected>
							0
						</subjectsAffected>
						<subjectsExposed>
							132
						</subjectsExposed>
						<occurrencesCausallyRelatedToTreatment>
							0
						</occurrencesCausallyRelatedToTreatment>
						<fatalities>
							<deaths>
								0
							</deaths>
							<deathsCausallyRelatedToTreatment>
								0
							</deathsCausallyRelatedToTreatment>
						</fatalities>
					</value>
					<value reportingGroupId="ReportingGroup-2">
						<occurrences>
							1
						</occurrences>
						<subjectsAffected>
							1
						</subjectsAffected>
						<subjectsExposed>
							131
						</subjectsExposed>
						<occurrencesCausallyRelatedToTreatment>
							0
						</occurrencesCausallyRelatedToTreatment>
						<fatalities>
							<deaths>
								0
							</deaths>
							<deathsCausallyRelatedToTreatment>
								0
							</deathsCausallyRelatedToTreatment>
						</fatalities>
					</value>
					<value reportingGroupId="ReportingGroup-3">
						<occurrences>
							0
						</occurrences>
						<subjectsAffected>
							0
						</subjectsAffected>
						<subjectsExposed>
							133
						</subjectsExposed>
						<occurrencesCausallyRelatedToTreatment>
							0
						</occurrencesCausallyRelatedToTreatment>
						<fatalities>
							<deaths>
								0
							</deaths>
							<deathsCausallyRelatedToTreatment>
								0
							</deathsCausallyRelatedToTreatment>
						</fatalities>
					</value>
				</values>
			</seriousAdverseEvent>
			<seriousAdverseEvent>
				<term>
					Blood pressure increased
				</term>
				<organSystem>
					<eutctId>
						100000004848
					</eutctId>
					<version>
						18
					</version>
				</organSystem>
				<assessmentMethod>
					<value>
						ADV_EVT_ASSESS_TYPE.systematic
					</value>
				</assessmentMethod>
				<dictionaryOverridden>
					false
				</dictionaryOverridden>
				<values>
					<value reportingGroupId="ReportingGroup-1">
						<occurrences>
							1
						</occurrences>
						<subjectsAffected>
							1
						</subjectsAffected>
						<subjectsExposed>
							132
						</subjectsExposed>
						<occurrencesCausallyRelatedToTreatment>
							0
						</occurrencesCausallyRelatedToTreatment>
						<fatalities>
							<deaths>
								0
							</deaths>
							<deathsCausallyRelatedToTreatment>
								0
							</deathsCausallyRelatedToTreatment>
						</fatalities>
					</value>
					<value reportingGroupId="ReportingGroup-2">
						<occurrences>
							0
						</occurrences>
						<subjectsAffected>
							0
						</subjectsAffected>
						<subjectsExposed>
							131
						</subjectsExposed>
						<occurrencesCausallyRelatedToTreatment>
							0
						</occurrencesCausallyRelatedToTreatment>
						<fatalities>
							<deaths>
								0
							</deaths>
							<deathsCausallyRelatedToTreatment>
								0
							</deathsCausallyRelatedToTreatment>
						</fatalities>
					</value>
					<value reportingGroupId="ReportingGroup-3">
						<occurrences>
							0
						</occurrences>
						<subjectsAffected>
							0
						</subjectsAffected>
						<subjectsExposed>
							133
						</subjectsExposed>
						<occurrencesCausallyRelatedToTreatment>
							0
						</occurrencesCausallyRelatedToTreatment>
						<fatalities>
							<deaths>
								0
							</deaths>
							<deathsCausallyRelatedToTreatment>
								0
							</deathsCausallyRelatedToTreatment>
						</fatalities>
					</value>
				</values>
			</seriousAdverseEvent>
			<seriousAdverseEvent>
				<term>
					Bronchitis
				</term>
				<organSystem>
					<eutctId>
						100000004862
					</eutctId>
					<version>
						18
					</version>
				</organSystem>
				<assessmentMethod>
					<value>
						ADV_EVT_ASSESS_TYPE.systematic
					</value>
				</assessmentMethod>
				<dictionaryOverridden>
					false
				</dictionaryOverridden>
				<values>
					<value reportingGroupId="ReportingGroup-1">
						<occurrences>
							0
						</occurrences>
						<subjectsAffected>
							0
						</subjectsAffected>
						<subjectsExposed>
							132
						</subjectsExposed>
						<occurrencesCausallyRelatedToTreatment>
							0
						</occurrencesCausallyRelatedToTreatment>
						<fatalities>
							<deaths>
								0
							</deaths>
							<deathsCausallyRelatedToTreatment>
								0
							</deathsCausallyRelatedToTreatment>
						</fatalities>
					</value>
					<value reportingGroupId="ReportingGroup-2">
						<occurrences>
							0
						</occurrences>
						<subjectsAffected>
							0
						</subjectsAffected>
						<subjectsExposed>
							131
						</subjectsExposed>
						<occurrencesCausallyRelatedToTreatment>
							0
						</occurrencesCausallyRelatedToTreatment>
						<fatalities>
							<deaths>
								0
							</deaths>
							<deathsCausallyRelatedToTreatment>
								0
							</deathsCausallyRelatedToTreatment>
						</fatalities>
					</value>
					<value reportingGroupId="ReportingGroup-3">
						<occurrences>
							1
						</occurrences>
						<subjectsAffected>
							1
						</subjectsAffected>
						<subjectsExposed>
							133
						</subjectsExposed>
						<occurrencesCausallyRelatedToTreatment>
							0
						</occurrencesCausallyRelatedToTreatment>
						<fatalities>
							<deaths>
								0
							</deaths>
							<deathsCausallyRelatedToTreatment>
								0
							</deathsCausallyRelatedToTreatment>
						</fatalities>
					</value>
				</values>
			</seriousAdverseEvent>
			<seriousAdverseEvent>
				<term>
					Cardiac failure
				</term>
				<organSystem>
					<eutctId>
						100000004849
					</eutctId>
					<version>
						18
					</version>
				</organSystem>
				<assessmentMethod>
					<value>
						ADV_EVT_ASSESS_TYPE.systematic
					</value>
				</assessmentMethod>
				<dictionaryOverridden>
					false
				</dictionaryOverridden>
				<values>
					<value reportingGroupId="ReportingGroup-1">
						<occurrences>
							0
						</occurrences>
						<subjectsAffected>
							0
						</subjectsAffected>
						<subjectsExposed>
							132
						</subjectsExposed>
						<occurrencesCausallyRelatedToTreatment>
							0
						</occurrencesCausallyRelatedToTreatment>
						<fatalities>
							<deaths>
								0
							</deaths>
							<deathsCausallyRelatedToTreatment>
								0
							</deathsCausallyRelatedToTreatment>
						</fatalities>
					</value>
					<value reportingGroupId="ReportingGroup-2">
						<occurrences>
							0
						</occurrences>
						<subjectsAffected>
							0
						</subjectsAffected>
						<subjectsExposed>
							131
						</subjectsExposed>
						<occurrencesCausallyRelatedToTreatment>
							0
						</occurrencesCausallyRelatedToTreatment>
						<fatalities>
							<deaths>
								0
							</deaths>
							<deathsCausallyRelatedToTreatment>
								0
							</deathsCausallyRelatedToTreatment>
						</fatalities>
					</value>
					<value reportingGroupId="ReportingGroup-3">
						<occurrences>
							1
						</occurrences>
						<subjectsAffected>
							1
						</subjectsAffected>
						<subjectsExposed>
							133
						</subjectsExposed>
						<occurrencesCausallyRelatedToTreatment>
							0
						</occurrencesCausallyRelatedToTreatment>
						<fatalities>
							<deaths>
								0
							</deaths>
							<deathsCausallyRelatedToTreatment>
								0
							</deathsCausallyRelatedToTreatment>
						</fatalities>
					</value>
				</values>
			</seriousAdverseEvent>
			<seriousAdverseEvent>
				<term>
					Carotid artery stenosis
				</term>
				<organSystem>
					<eutctId>
						100000004852
					</eutctId>
					<version>
						18
					</version>
				</organSystem>
				<assessmentMethod>
					<value>
						ADV_EVT_ASSESS_TYPE.systematic
					</value>
				</assessmentMethod>
				<dictionaryOverridden>
					false
				</dictionaryOverridden>
				<values>
					<value reportingGroupId="ReportingGroup-1">
						<occurrences>
							0
						</occurrences>
						<subjectsAffected>
							0
						</subjectsAffected>
						<subjectsExposed>
							132
						</subjectsExposed>
						<occurrencesCausallyRelatedToTreatment>
							0
						</occurrencesCausallyRelatedToTreatment>
						<fatalities>
							<deaths>
								0
							</deaths>
							<deathsCausallyRelatedToTreatment>
								0
							</deathsCausallyRelatedToTreatment>
						</fatalities>
					</value>
					<value reportingGroupId="ReportingGroup-2">
						<occurrences>
							1
						</occurrences>
						<subjectsAffected>
							1
						</subjectsAffected>
						<subjectsExposed>
							131
						</subjectsExposed>
						<occurrencesCausallyRelatedToTreatment>
							0
						</occurrencesCausallyRelatedToTreatment>
						<fatalities>
							<deaths>
								0
							</deaths>
							<deathsCausallyRelatedToTreatment>
								0
							</deathsCausallyRelatedToTreatment>
						</fatalities>
					</value>
					<value reportingGroupId="ReportingGroup-3">
						<occurrences>
							0
						</occurrences>
						<subjectsAffected>
							0
						</subjectsAffected>
						<subjectsExposed>
							133
						</subjectsExposed>
						<occurrencesCausallyRelatedToTreatment>
							0
						</occurrencesCausallyRelatedToTreatment>
						<fatalities>
							<deaths>
								0
							</deaths>
							<deathsCausallyRelatedToTreatment>
								0
							</deathsCausallyRelatedToTreatment>
						</fatalities>
					</value>
				</values>
			</seriousAdverseEvent>
			<seriousAdverseEvent>
				<term>
					Carotid endarterectomy
				</term>
				<organSystem>
					<eutctId>
						100000004865
					</eutctId>
					<version>
						18
					</version>
				</organSystem>
				<assessmentMethod>
					<value>
						ADV_EVT_ASSESS_TYPE.systematic
					</value>
				</assessmentMethod>
				<dictionaryOverridden>
					false
				</dictionaryOverridden>
				<values>
					<value reportingGroupId="ReportingGroup-1">
						<occurrences>
							0
						</occurrences>
						<subjectsAffected>
							0
						</subjectsAffected>
						<subjectsExposed>
							132
						</subjectsExposed>
						<occurrencesCausallyRelatedToTreatment>
							0
						</occurrencesCausallyRelatedToTreatment>
						<fatalities>
							<deaths>
								0
							</deaths>
							<deathsCausallyRelatedToTreatment>
								0
							</deathsCausallyRelatedToTreatment>
						</fatalities>
					</value>
					<value reportingGroupId="ReportingGroup-2">
						<occurrences>
							1
						</occurrences>
						<subjectsAffected>
							1
						</subjectsAffected>
						<subjectsExposed>
							131
						</subjectsExposed>
						<occurrencesCausallyRelatedToTreatment>
							0
						</occurrencesCausallyRelatedToTreatment>
						<fatalities>
							<deaths>
								0
							</deaths>
							<deathsCausallyRelatedToTreatment>
								0
							</deathsCausallyRelatedToTreatment>
						</fatalities>
					</value>
					<value reportingGroupId="ReportingGroup-3">
						<occurrences>
							0
						</occurrences>
						<subjectsAffected>
							0
						</subjectsAffected>
						<subjectsExposed>
							133
						</subjectsExposed>
						<occurrencesCausallyRelatedToTreatment>
							0
						</occurrencesCausallyRelatedToTreatment>
						<fatalities>
							<deaths>
								0
							</deaths>
							<deathsCausallyRelatedToTreatment>
								0
							</deathsCausallyRelatedToTreatment>
						</fatalities>
					</value>
				</values>
			</seriousAdverseEvent>
			<seriousAdverseEvent>
				<term>
					Cataract
				</term>
				<organSystem>
					<eutctId>
						100000004853
					</eutctId>
					<version>
						18
					</version>
				</organSystem>
				<assessmentMethod>
					<value>
						ADV_EVT_ASSESS_TYPE.systematic
					</value>
				</assessmentMethod>
				<dictionaryOverridden>
					false
				</dictionaryOverridden>
				<values>
					<value reportingGroupId="ReportingGroup-1">
						<occurrences>
							0
						</occurrences>
						<subjectsAffected>
							0
						</subjectsAffected>
						<subjectsExposed>
							132
						</subjectsExposed>
						<occurrencesCausallyRelatedToTreatment>
							0
						</occurrencesCausallyRelatedToTreatment>
						<fatalities>
							<deaths>
								0
							</deaths>
							<deathsCausallyRelatedToTreatment>
								0
							</deathsCausallyRelatedToTreatment>
						</fatalities>
					</value>
					<value reportingGroupId="ReportingGroup-2">
						<occurrences>
							0
						</occurrences>
						<subjectsAffected>
							0
						</subjectsAffected>
						<subjectsExposed>
							131
						</subjectsExposed>
						<occurrencesCausallyRelatedToTreatment>
							0
						</occurrencesCausallyRelatedToTreatment>
						<fatalities>
							<deaths>
								0
							</deaths>
							<deathsCausallyRelatedToTreatment>
								0
							</deathsCausallyRelatedToTreatment>
						</fatalities>
					</value>
					<value reportingGroupId="ReportingGroup-3">
						<occurrences>
							1
						</occurrences>
						<subjectsAffected>
							1
						</subjectsAffected>
						<subjectsExposed>
							133
						</subjectsExposed>
						<occurrencesCausallyRelatedToTreatment>
							0
						</occurrencesCausallyRelatedToTreatment>
						<fatalities>
							<deaths>
								0
							</deaths>
							<deathsCausallyRelatedToTreatment>
								0
							</deathsCausallyRelatedToTreatment>
						</fatalities>
					</value>
				</values>
			</seriousAdverseEvent>
			<seriousAdverseEvent>
				<term>
					Cholecystitis acute
				</term>
				<organSystem>
					<eutctId>
						100000004871
					</eutctId>
					<version>
						18
					</version>
				</organSystem>
				<assessmentMethod>
					<value>
						ADV_EVT_ASSESS_TYPE.systematic
					</value>
				</assessmentMethod>
				<dictionaryOverridden>
					false
				</dictionaryOverridden>
				<values>
					<value reportingGroupId="ReportingGroup-1">
						<occurrences>
							0
						</occurrences>
						<subjectsAffected>
							0
						</subjectsAffected>
						<subjectsExposed>
							132
						</subjectsExposed>
						<occurrencesCausallyRelatedToTreatment>
							0
						</occurrencesCausallyRelatedToTreatment>
						<fatalities>
							<deaths>
								0
							</deaths>
							<deathsCausallyRelatedToTreatment>
								0
							</deathsCausallyRelatedToTreatment>
						</fatalities>
					</value>
					<value reportingGroupId="ReportingGroup-2">
						<occurrences>
							1
						</occurrences>
						<subjectsAffected>
							1
						</subjectsAffected>
						<subjectsExposed>
							131
						</subjectsExposed>
						<occurrencesCausallyRelatedToTreatment>
							0
						</occurrencesCausallyRelatedToTreatment>
						<fatalities>
							<deaths>
								0
							</deaths>
							<deathsCausallyRelatedToTreatment>
								0
							</deathsCausallyRelatedToTreatment>
						</fatalities>
					</value>
					<value reportingGroupId="ReportingGroup-3">
						<occurrences>
							0
						</occurrences>
						<subjectsAffected>
							0
						</subjectsAffected>
						<subjectsExposed>
							133
						</subjectsExposed>
						<occurrencesCausallyRelatedToTreatment>
							0
						</occurrencesCausallyRelatedToTreatment>
						<fatalities>
							<deaths>
								0
							</deaths>
							<deathsCausallyRelatedToTreatment>
								0
							</deathsCausallyRelatedToTreatment>
						</fatalities>
					</value>
				</values>
			</seriousAdverseEvent>
			<seriousAdverseEvent>
				<term>
					Clostridium difficile colitis
				</term>
				<organSystem>
					<eutctId>
						100000004862
					</eutctId>
					<version>
						18
					</version>
				</organSystem>
				<assessmentMethod>
					<value>
						ADV_EVT_ASSESS_TYPE.systematic
					</value>
				</assessmentMethod>
				<dictionaryOverridden>
					false
				</dictionaryOverridden>
				<values>
					<value reportingGroupId="ReportingGroup-1">
						<occurrences>
							0
						</occurrences>
						<subjectsAffected>
							0
						</subjectsAffected>
						<subjectsExposed>
							132
						</subjectsExposed>
						<occurrencesCausallyRelatedToTreatment>
							0
						</occurrencesCausallyRelatedToTreatment>
						<fatalities>
							<deaths>
								0
							</deaths>
							<deathsCausallyRelatedToTreatment>
								0
							</deathsCausallyRelatedToTreatment>
						</fatalities>
					</value>
					<value reportingGroupId="ReportingGroup-2">
						<occurrences>
							1
						</occurrences>
						<subjectsAffected>
							1
						</subjectsAffected>
						<subjectsExposed>
							131
						</subjectsExposed>
						<occurrencesCausallyRelatedToTreatment>
							1
						</occurrencesCausallyRelatedToTreatment>
						<fatalities>
							<deaths>
								0
							</deaths>
							<deathsCausallyRelatedToTreatment>
								0
							</deathsCausallyRelatedToTreatment>
						</fatalities>
					</value>
					<value reportingGroupId="ReportingGroup-3">
						<occurrences>
							0
						</occurrences>
						<subjectsAffected>
							0
						</subjectsAffected>
						<subjectsExposed>
							133
						</subjectsExposed>
						<occurrencesCausallyRelatedToTreatment>
							0
						</occurrencesCausallyRelatedToTreatment>
						<fatalities>
							<deaths>
								0
							</deaths>
							<deathsCausallyRelatedToTreatment>
								0
							</deathsCausallyRelatedToTreatment>
						</fatalities>
					</value>
				</values>
			</seriousAdverseEvent>
			<seriousAdverseEvent>
				<term>
					Coronary arterial stent insertion
				</term>
				<organSystem>
					<eutctId>
						100000004865
					</eutctId>
					<version>
						18
					</version>
				</organSystem>
				<assessmentMethod>
					<value>
						ADV_EVT_ASSESS_TYPE.systematic
					</value>
				</assessmentMethod>
				<dictionaryOverridden>
					false
				</dictionaryOverridden>
				<values>
					<value reportingGroupId="ReportingGroup-1">
						<occurrences>
							1
						</occurrences>
						<subjectsAffected>
							1
						</subjectsAffected>
						<subjectsExposed>
							132
						</subjectsExposed>
						<occurrencesCausallyRelatedToTreatment>
							0
						</occurrencesCausallyRelatedToTreatment>
						<fatalities>
							<deaths>
								0
							</deaths>
							<deathsCausallyRelatedToTreatment>
								0
							</deathsCausallyRelatedToTreatment>
						</fatalities>
					</value>
					<value reportingGroupId="ReportingGroup-2">
						<occurrences>
							0
						</occurrences>
						<subjectsAffected>
							0
						</subjectsAffected>
						<subjectsExposed>
							131
						</subjectsExposed>
						<occurrencesCausallyRelatedToTreatment>
							0
						</occurrencesCausallyRelatedToTreatment>
						<fatalities>
							<deaths>
								0
							</deaths>
							<deathsCausallyRelatedToTreatment>
								0
							</deathsCausallyRelatedToTreatment>
						</fatalities>
					</value>
					<value reportingGroupId="ReportingGroup-3">
						<occurrences>
							0
						</occurrences>
						<subjectsAffected>
							0
						</subjectsAffected>
						<subjectsExposed>
							133
						</subjectsExposed>
						<occurrencesCausallyRelatedToTreatment>
							0
						</occurrencesCausallyRelatedToTreatment>
						<fatalities>
							<deaths>
								0
							</deaths>
							<deathsCausallyRelatedToTreatment>
								0
							</deathsCausallyRelatedToTreatment>
						</fatalities>
					</value>
				</values>
			</seriousAdverseEvent>
			<seriousAdverseEvent>
				<term>
					Coronary artery bypass
				</term>
				<organSystem>
					<eutctId>
						100000004865
					</eutctId>
					<version>
						18
					</version>
				</organSystem>
				<assessmentMethod>
					<value>
						ADV_EVT_ASSESS_TYPE.systematic
					</value>
				</assessmentMethod>
				<dictionaryOverridden>
					false
				</dictionaryOverridden>
				<values>
					<value reportingGroupId="ReportingGroup-1">
						<occurrences>
							0
						</occurrences>
						<subjectsAffected>
							0
						</subjectsAffected>
						<subjectsExposed>
							132
						</subjectsExposed>
						<occurrencesCausallyRelatedToTreatment>
							0
						</occurrencesCausallyRelatedToTreatment>
						<fatalities>
							<deaths>
								0
							</deaths>
							<deathsCausallyRelatedToTreatment>
								0
							</deathsCausallyRelatedToTreatment>
						</fatalities>
					</value>
					<value reportingGroupId="ReportingGroup-2">
						<occurrences>
							1
						</occurrences>
						<subjectsAffected>
							1
						</subjectsAffected>
						<subjectsExposed>
							131
						</subjectsExposed>
						<occurrencesCausallyRelatedToTreatment>
							0
						</occurrencesCausallyRelatedToTreatment>
						<fatalities>
							<deaths>
								0
							</deaths>
							<deathsCausallyRelatedToTreatment>
								0
							</deathsCausallyRelatedToTreatment>
						</fatalities>
					</value>
					<value reportingGroupId="ReportingGroup-3">
						<occurrences>
							1
						</occurrences>
						<subjectsAffected>
							1
						</subjectsAffected>
						<subjectsExposed>
							133
						</subjectsExposed>
						<occurrencesCausallyRelatedToTreatment>
							0
						</occurrencesCausallyRelatedToTreatment>
						<fatalities>
							<deaths>
								0
							</deaths>
							<deathsCausallyRelatedToTreatment>
								0
							</deathsCausallyRelatedToTreatment>
						</fatalities>
					</value>
				</values>
			</seriousAdverseEvent>
			<seriousAdverseEvent>
				<term>
					Coronary artery disease
				</term>
				<organSystem>
					<eutctId>
						100000004849
					</eutctId>
					<version>
						18
					</version>
				</organSystem>
				<assessmentMethod>
					<value>
						ADV_EVT_ASSESS_TYPE.systematic
					</value>
				</assessmentMethod>
				<dictionaryOverridden>
					false
				</dictionaryOverridden>
				<values>
					<value reportingGroupId="ReportingGroup-1">
						<occurrences>
							1
						</occurrences>
						<subjectsAffected>
							1
						</subjectsAffected>
						<subjectsExposed>
							132
						</subjectsExposed>
						<occurrencesCausallyRelatedToTreatment>
							0
						</occurrencesCausallyRelatedToTreatment>
						<fatalities>
							<deaths>
								0
							</deaths>
							<deathsCausallyRelatedToTreatment>
								0
							</deathsCausallyRelatedToTreatment>
						</fatalities>
					</value>
					<value reportingGroupId="ReportingGroup-2">
						<occurrences>
							0
						</occurrences>
						<subjectsAffected>
							0
						</subjectsAffected>
						<subjectsExposed>
							131
						</subjectsExposed>
						<occurrencesCausallyRelatedToTreatment>
							0
						</occurrencesCausallyRelatedToTreatment>
						<fatalities>
							<deaths>
								0
							</deaths>
							<deathsCausallyRelatedToTreatment>
								0
							</deathsCausallyRelatedToTreatment>
						</fatalities>
					</value>
					<value reportingGroupId="ReportingGroup-3">
						<occurrences>
							0
						</occurrences>
						<subjectsAffected>
							0
						</subjectsAffected>
						<subjectsExposed>
							133
						</subjectsExposed>
						<occurrencesCausallyRelatedToTreatment>
							0
						</occurrencesCausallyRelatedToTreatment>
						<fatalities>
							<deaths>
								0
							</deaths>
							<deathsCausallyRelatedToTreatment>
								0
							</deathsCausallyRelatedToTreatment>
						</fatalities>
					</value>
				</values>
			</seriousAdverseEvent>
			<seriousAdverseEvent>
				<term>
					Depression
				</term>
				<organSystem>
					<eutctId>
						100000004873
					</eutctId>
					<version>
						18
					</version>
				</organSystem>
				<assessmentMethod>
					<value>
						ADV_EVT_ASSESS_TYPE.systematic
					</value>
				</assessmentMethod>
				<dictionaryOverridden>
					false
				</dictionaryOverridden>
				<values>
					<value reportingGroupId="ReportingGroup-1">
						<occurrences>
							0
						</occurrences>
						<subjectsAffected>
							0
						</subjectsAffected>
						<subjectsExposed>
							132
						</subjectsExposed>
						<occurrencesCausallyRelatedToTreatment>
							0
						</occurrencesCausallyRelatedToTreatment>
						<fatalities>
							<deaths>
								0
							</deaths>
							<deathsCausallyRelatedToTreatment>
								0
							</deathsCausallyRelatedToTreatment>
						</fatalities>
					</value>
					<value reportingGroupId="ReportingGroup-2">
						<occurrences>
							0
						</occurrences>
						<subjectsAffected>
							0
						</subjectsAffected>
						<subjectsExposed>
							131
						</subjectsExposed>
						<occurrencesCausallyRelatedToTreatment>
							0
						</occurrencesCausallyRelatedToTreatment>
						<fatalities>
							<deaths>
								0
							</deaths>
							<deathsCausallyRelatedToTreatment>
								0
							</deathsCausallyRelatedToTreatment>
						</fatalities>
					</value>
					<value reportingGroupId="ReportingGroup-3">
						<occurrences>
							1
						</occurrences>
						<subjectsAffected>
							1
						</subjectsAffected>
						<subjectsExposed>
							133
						</subjectsExposed>
						<occurrencesCausallyRelatedToTreatment>
							0
						</occurrencesCausallyRelatedToTreatment>
						<fatalities>
							<deaths>
								0
							</deaths>
							<deathsCausallyRelatedToTreatment>
								0
							</deathsCausallyRelatedToTreatment>
						</fatalities>
					</value>
				</values>
			</seriousAdverseEvent>
			<seriousAdverseEvent>
				<term>
					Diabetes mellitus inadequate control
				</term>
				<organSystem>
					<eutctId>
						100000004861
					</eutctId>
					<version>
						18
					</version>
				</organSystem>
				<assessmentMethod>
					<value>
						ADV_EVT_ASSESS_TYPE.systematic
					</value>
				</assessmentMethod>
				<dictionaryOverridden>
					false
				</dictionaryOverridden>
				<values>
					<value reportingGroupId="ReportingGroup-1">
						<occurrences>
							0
						</occurrences>
						<subjectsAffected>
							0
						</subjectsAffected>
						<subjectsExposed>
							132
						</subjectsExposed>
						<occurrencesCausallyRelatedToTreatment>
							0
						</occurrencesCausallyRelatedToTreatment>
						<fatalities>
							<deaths>
								0
							</deaths>
							<deathsCausallyRelatedToTreatment>
								0
							</deathsCausallyRelatedToTreatment>
						</fatalities>
					</value>
					<value reportingGroupId="ReportingGroup-2">
						<occurrences>
							0
						</occurrences>
						<subjectsAffected>
							0
						</subjectsAffected>
						<subjectsExposed>
							131
						</subjectsExposed>
						<occurrencesCausallyRelatedToTreatment>
							0
						</occurrencesCausallyRelatedToTreatment>
						<fatalities>
							<deaths>
								0
							</deaths>
							<deathsCausallyRelatedToTreatment>
								0
							</deathsCausallyRelatedToTreatment>
						</fatalities>
					</value>
					<value reportingGroupId="ReportingGroup-3">
						<occurrences>
							1
						</occurrences>
						<subjectsAffected>
							1
						</subjectsAffected>
						<subjectsExposed>
							133
						</subjectsExposed>
						<occurrencesCausallyRelatedToTreatment>
							0
						</occurrencesCausallyRelatedToTreatment>
						<fatalities>
							<deaths>
								0
							</deaths>
							<deathsCausallyRelatedToTreatment>
								0
							</deathsCausallyRelatedToTreatment>
						</fatalities>
					</value>
				</values>
			</seriousAdverseEvent>
			<seriousAdverseEvent>
				<term>
					Diverticulitis
				</term>
				<organSystem>
					<eutctId>
						100000004862
					</eutctId>
					<version>
						18
					</version>
				</organSystem>
				<assessmentMethod>
					<value>
						ADV_EVT_ASSESS_TYPE.systematic
					</value>
				</assessmentMethod>
				<dictionaryOverridden>
					false
				</dictionaryOverridden>
				<values>
					<value reportingGroupId="ReportingGroup-1">
						<occurrences>
							0
						</occurrences>
						<subjectsAffected>
							0
						</subjectsAffected>
						<subjectsExposed>
							132
						</subjectsExposed>
						<occurrencesCausallyRelatedToTreatment>
							0
						</occurrencesCausallyRelatedToTreatment>
						<fatalities>
							<deaths>
								0
							</deaths>
							<deathsCausallyRelatedToTreatment>
								0
							</deathsCausallyRelatedToTreatment>
						</fatalities>
					</value>
					<value reportingGroupId="ReportingGroup-2">
						<occurrences>
							0
						</occurrences>
						<subjectsAffected>
							0
						</subjectsAffected>
						<subjectsExposed>
							131
						</subjectsExposed>
						<occurrencesCausallyRelatedToTreatment>
							0
						</occurrencesCausallyRelatedToTreatment>
						<fatalities>
							<deaths>
								0
							</deaths>
							<deathsCausallyRelatedToTreatment>
								0
							</deathsCausallyRelatedToTreatment>
						</fatalities>
					</value>
					<value reportingGroupId="ReportingGroup-3">
						<occurrences>
							1
						</occurrences>
						<subjectsAffected>
							1
						</subjectsAffected>
						<subjectsExposed>
							133
						</subjectsExposed>
						<occurrencesCausallyRelatedToTreatment>
							0
						</occurrencesCausallyRelatedToTreatment>
						<fatalities>
							<deaths>
								0
							</deaths>
							<deathsCausallyRelatedToTreatment>
								0
							</deathsCausallyRelatedToTreatment>
						</fatalities>
					</value>
				</values>
			</seriousAdverseEvent>
			<seriousAdverseEvent>
				<term>
					Drug hypersensitivity
				</term>
				<organSystem>
					<eutctId>
						100000004870
					</eutctId>
					<version>
						18
					</version>
				</organSystem>
				<assessmentMethod>
					<value>
						ADV_EVT_ASSESS_TYPE.systematic
					</value>
				</assessmentMethod>
				<dictionaryOverridden>
					false
				</dictionaryOverridden>
				<values>
					<value reportingGroupId="ReportingGroup-1">
						<occurrences>
							0
						</occurrences>
						<subjectsAffected>
							0
						</subjectsAffected>
						<subjectsExposed>
							132
						</subjectsExposed>
						<occurrencesCausallyRelatedToTreatment>
							0
						</occurrencesCausallyRelatedToTreatment>
						<fatalities>
							<deaths>
								0
							</deaths>
							<deathsCausallyRelatedToTreatment>
								0
							</deathsCausallyRelatedToTreatment>
						</fatalities>
					</value>
					<value reportingGroupId="ReportingGroup-2">
						<occurrences>
							1
						</occurrences>
						<subjectsAffected>
							1
						</subjectsAffected>
						<subjectsExposed>
							131
						</subjectsExposed>
						<occurrencesCausallyRelatedToTreatment>
							0
						</occurrencesCausallyRelatedToTreatment>
						<fatalities>
							<deaths>
								0
							</deaths>
							<deathsCausallyRelatedToTreatment>
								0
							</deathsCausallyRelatedToTreatment>
						</fatalities>
					</value>
					<value reportingGroupId="ReportingGroup-3">
						<occurrences>
							0
						</occurrences>
						<subjectsAffected>
							0
						</subjectsAffected>
						<subjectsExposed>
							133
						</subjectsExposed>
						<occurrencesCausallyRelatedToTreatment>
							0
						</occurrencesCausallyRelatedToTreatment>
						<fatalities>
							<deaths>
								0
							</deaths>
							<deathsCausallyRelatedToTreatment>
								0
							</deathsCausallyRelatedToTreatment>
						</fatalities>
					</value>
				</values>
			</seriousAdverseEvent>
			<seriousAdverseEvent>
				<term>
					Femoral artery occlusion
				</term>
				<organSystem>
					<eutctId>
						100000004866
					</eutctId>
					<version>
						18
					</version>
				</organSystem>
				<assessmentMethod>
					<value>
						ADV_EVT_ASSESS_TYPE.systematic
					</value>
				</assessmentMethod>
				<dictionaryOverridden>
					false
				</dictionaryOverridden>
				<values>
					<value reportingGroupId="ReportingGroup-1">
						<occurrences>
							0
						</occurrences>
						<subjectsAffected>
							0
						</subjectsAffected>
						<subjectsExposed>
							132
						</subjectsExposed>
						<occurrencesCausallyRelatedToTreatment>
							0
						</occurrencesCausallyRelatedToTreatment>
						<fatalities>
							<deaths>
								0
							</deaths>
							<deathsCausallyRelatedToTreatment>
								0
							</deathsCausallyRelatedToTreatment>
						</fatalities>
					</value>
					<value reportingGroupId="ReportingGroup-2">
						<occurrences>
							0
						</occurrences>
						<subjectsAffected>
							0
						</subjectsAffected>
						<subjectsExposed>
							131
						</subjectsExposed>
						<occurrencesCausallyRelatedToTreatment>
							0
						</occurrencesCausallyRelatedToTreatment>
						<fatalities>
							<deaths>
								0
							</deaths>
							<deathsCausallyRelatedToTreatment>
								0
							</deathsCausallyRelatedToTreatment>
						</fatalities>
					</value>
					<value reportingGroupId="ReportingGroup-3">
						<occurrences>
							1
						</occurrences>
						<subjectsAffected>
							1
						</subjectsAffected>
						<subjectsExposed>
							133
						</subjectsExposed>
						<occurrencesCausallyRelatedToTreatment>
							0
						</occurrencesCausallyRelatedToTreatment>
						<fatalities>
							<deaths>
								0
							</deaths>
							<deathsCausallyRelatedToTreatment>
								0
							</deathsCausallyRelatedToTreatment>
						</fatalities>
					</value>
				</values>
			</seriousAdverseEvent>
			<seriousAdverseEvent>
				<term>
					Gastrooesophageal reflux disease
				</term>
				<organSystem>
					<eutctId>
						100000004856
					</eutctId>
					<version>
						18
					</version>
				</organSystem>
				<assessmentMethod>
					<value>
						ADV_EVT_ASSESS_TYPE.systematic
					</value>
				</assessmentMethod>
				<dictionaryOverridden>
					false
				</dictionaryOverridden>
				<values>
					<value reportingGroupId="ReportingGroup-1">
						<occurrences>
							0
						</occurrences>
						<subjectsAffected>
							0
						</subjectsAffected>
						<subjectsExposed>
							132
						</subjectsExposed>
						<occurrencesCausallyRelatedToTreatment>
							0
						</occurrencesCausallyRelatedToTreatment>
						<fatalities>
							<deaths>
								0
							</deaths>
							<deathsCausallyRelatedToTreatment>
								0
							</deathsCausallyRelatedToTreatment>
						</fatalities>
					</value>
					<value reportingGroupId="ReportingGroup-2">
						<occurrences>
							1
						</occurrences>
						<subjectsAffected>
							1
						</subjectsAffected>
						<subjectsExposed>
							131
						</subjectsExposed>
						<occurrencesCausallyRelatedToTreatment>
							0
						</occurrencesCausallyRelatedToTreatment>
						<fatalities>
							<deaths>
								0
							</deaths>
							<deathsCausallyRelatedToTreatment>
								0
							</deathsCausallyRelatedToTreatment>
						</fatalities>
					</value>
					<value reportingGroupId="ReportingGroup-3">
						<occurrences>
							0
						</occurrences>
						<subjectsAffected>
							0
						</subjectsAffected>
						<subjectsExposed>
							133
						</subjectsExposed>
						<occurrencesCausallyRelatedToTreatment>
							0
						</occurrencesCausallyRelatedToTreatment>
						<fatalities>
							<deaths>
								0
							</deaths>
							<deathsCausallyRelatedToTreatment>
								0
							</deathsCausallyRelatedToTreatment>
						</fatalities>
					</value>
				</values>
			</seriousAdverseEvent>
			<seriousAdverseEvent>
				<term>
					Hypoglycaemia
				</term>
				<organSystem>
					<eutctId>
						100000004861
					</eutctId>
					<version>
						18
					</version>
				</organSystem>
				<assessmentMethod>
					<value>
						ADV_EVT_ASSESS_TYPE.systematic
					</value>
				</assessmentMethod>
				<dictionaryOverridden>
					false
				</dictionaryOverridden>
				<values>
					<value reportingGroupId="ReportingGroup-1">
						<occurrences>
							0
						</occurrences>
						<subjectsAffected>
							0
						</subjectsAffected>
						<subjectsExposed>
							132
						</subjectsExposed>
						<occurrencesCausallyRelatedToTreatment>
							0
						</occurrencesCausallyRelatedToTreatment>
						<fatalities>
							<deaths>
								0
							</deaths>
							<deathsCausallyRelatedToTreatment>
								0
							</deathsCausallyRelatedToTreatment>
						</fatalities>
					</value>
					<value reportingGroupId="ReportingGroup-2">
						<occurrences>
							1
						</occurrences>
						<subjectsAffected>
							1
						</subjectsAffected>
						<subjectsExposed>
							131
						</subjectsExposed>
						<occurrencesCausallyRelatedToTreatment>
							1
						</occurrencesCausallyRelatedToTreatment>
						<fatalities>
							<deaths>
								0
							</deaths>
							<deathsCausallyRelatedToTreatment>
								0
							</deathsCausallyRelatedToTreatment>
						</fatalities>
					</value>
					<value reportingGroupId="ReportingGroup-3">
						<occurrences>
							0
						</occurrences>
						<subjectsAffected>
							0
						</subjectsAffected>
						<subjectsExposed>
							133
						</subjectsExposed>
						<occurrencesCausallyRelatedToTreatment>
							0
						</occurrencesCausallyRelatedToTreatment>
						<fatalities>
							<deaths>
								0
							</deaths>
							<deathsCausallyRelatedToTreatment>
								0
							</deathsCausallyRelatedToTreatment>
						</fatalities>
					</value>
				</values>
			</seriousAdverseEvent>
			<seriousAdverseEvent>
				<term>
					Hypoglycaemic unconsciousness
				</term>
				<organSystem>
					<eutctId>
						100000004852
					</eutctId>
					<version>
						18
					</version>
				</organSystem>
				<assessmentMethod>
					<value>
						ADV_EVT_ASSESS_TYPE.systematic
					</value>
				</assessmentMethod>
				<dictionaryOverridden>
					false
				</dictionaryOverridden>
				<values>
					<value reportingGroupId="ReportingGroup-1">
						<occurrences>
							0
						</occurrences>
						<subjectsAffected>
							0
						</subjectsAffected>
						<subjectsExposed>
							132
						</subjectsExposed>
						<occurrencesCausallyRelatedToTreatment>
							0
						</occurrencesCausallyRelatedToTreatment>
						<fatalities>
							<deaths>
								0
							</deaths>
							<deathsCausallyRelatedToTreatment>
								0
							</deathsCausallyRelatedToTreatment>
						</fatalities>
					</value>
					<value reportingGroupId="ReportingGroup-2">
						<occurrences>
							1
						</occurrences>
						<subjectsAffected>
							1
						</subjectsAffected>
						<subjectsExposed>
							131
						</subjectsExposed>
						<occurrencesCausallyRelatedToTreatment>
							1
						</occurrencesCausallyRelatedToTreatment>
						<fatalities>
							<deaths>
								0
							</deaths>
							<deathsCausallyRelatedToTreatment>
								0
							</deathsCausallyRelatedToTreatment>
						</fatalities>
					</value>
					<value reportingGroupId="ReportingGroup-3">
						<occurrences>
							0
						</occurrences>
						<subjectsAffected>
							0
						</subjectsAffected>
						<subjectsExposed>
							133
						</subjectsExposed>
						<occurrencesCausallyRelatedToTreatment>
							0
						</occurrencesCausallyRelatedToTreatment>
						<fatalities>
							<deaths>
								0
							</deaths>
							<deathsCausallyRelatedToTreatment>
								0
							</deathsCausallyRelatedToTreatment>
						</fatalities>
					</value>
				</values>
			</seriousAdverseEvent>
			<seriousAdverseEvent>
				<term>
					Ischaemic stroke
				</term>
				<organSystem>
					<eutctId>
						100000004852
					</eutctId>
					<version>
						18
					</version>
				</organSystem>
				<assessmentMethod>
					<value>
						ADV_EVT_ASSESS_TYPE.systematic
					</value>
				</assessmentMethod>
				<dictionaryOverridden>
					false
				</dictionaryOverridden>
				<values>
					<value reportingGroupId="ReportingGroup-1">
						<occurrences>
							1
						</occurrences>
						<subjectsAffected>
							1
						</subjectsAffected>
						<subjectsExposed>
							132
						</subjectsExposed>
						<occurrencesCausallyRelatedToTreatment>
							0
						</occurrencesCausallyRelatedToTreatment>
						<fatalities>
							<deaths>
								0
							</deaths>
							<deathsCausallyRelatedToTreatment>
								0
							</deathsCausallyRelatedToTreatment>
						</fatalities>
					</value>
					<value reportingGroupId="ReportingGroup-2">
						<occurrences>
							0
						</occurrences>
						<subjectsAffected>
							0
						</subjectsAffected>
						<subjectsExposed>
							131
						</subjectsExposed>
						<occurrencesCausallyRelatedToTreatment>
							0
						</occurrencesCausallyRelatedToTreatment>
						<fatalities>
							<deaths>
								0
							</deaths>
							<deathsCausallyRelatedToTreatment>
								0
							</deathsCausallyRelatedToTreatment>
						</fatalities>
					</value>
					<value reportingGroupId="ReportingGroup-3">
						<occurrences>
							0
						</occurrences>
						<subjectsAffected>
							0
						</subjectsAffected>
						<subjectsExposed>
							133
						</subjectsExposed>
						<occurrencesCausallyRelatedToTreatment>
							0
						</occurrencesCausallyRelatedToTreatment>
						<fatalities>
							<deaths>
								0
							</deaths>
							<deathsCausallyRelatedToTreatment>
								0
							</deathsCausallyRelatedToTreatment>
						</fatalities>
					</value>
				</values>
			</seriousAdverseEvent>
			<seriousAdverseEvent>
				<term>
					Lumbar spinal stenosis
				</term>
				<organSystem>
					<eutctId>
						100000004859
					</eutctId>
					<version>
						18
					</version>
				</organSystem>
				<assessmentMethod>
					<value>
						ADV_EVT_ASSESS_TYPE.systematic
					</value>
				</assessmentMethod>
				<dictionaryOverridden>
					false
				</dictionaryOverridden>
				<values>
					<value reportingGroupId="ReportingGroup-1">
						<occurrences>
							0
						</occurrences>
						<subjectsAffected>
							0
						</subjectsAffected>
						<subjectsExposed>
							132
						</subjectsExposed>
						<occurrencesCausallyRelatedToTreatment>
							0
						</occurrencesCausallyRelatedToTreatment>
						<fatalities>
							<deaths>
								0
							</deaths>
							<deathsCausallyRelatedToTreatment>
								0
							</deathsCausallyRelatedToTreatment>
						</fatalities>
					</value>
					<value reportingGroupId="ReportingGroup-2">
						<occurrences>
							1
						</occurrences>
						<subjectsAffected>
							1
						</subjectsAffected>
						<subjectsExposed>
							131
						</subjectsExposed>
						<occurrencesCausallyRelatedToTreatment>
							0
						</occurrencesCausallyRelatedToTreatment>
						<fatalities>
							<deaths>
								0
							</deaths>
							<deathsCausallyRelatedToTreatment>
								0
							</deathsCausallyRelatedToTreatment>
						</fatalities>
					</value>
					<value reportingGroupId="ReportingGroup-3">
						<occurrences>
							0
						</occurrences>
						<subjectsAffected>
							0
						</subjectsAffected>
						<subjectsExposed>
							133
						</subjectsExposed>
						<occurrencesCausallyRelatedToTreatment>
							0
						</occurrencesCausallyRelatedToTreatment>
						<fatalities>
							<deaths>
								0
							</deaths>
							<deathsCausallyRelatedToTreatment>
								0
							</deathsCausallyRelatedToTreatment>
						</fatalities>
					</value>
				</values>
			</seriousAdverseEvent>
			<seriousAdverseEvent>
				<term>
					Meningitis aseptic
				</term>
				<organSystem>
					<eutctId>
						100000004862
					</eutctId>
					<version>
						18
					</version>
				</organSystem>
				<assessmentMethod>
					<value>
						ADV_EVT_ASSESS_TYPE.systematic
					</value>
				</assessmentMethod>
				<dictionaryOverridden>
					false
				</dictionaryOverridden>
				<values>
					<value reportingGroupId="ReportingGroup-1">
						<occurrences>
							0
						</occurrences>
						<subjectsAffected>
							0
						</subjectsAffected>
						<subjectsExposed>
							132
						</subjectsExposed>
						<occurrencesCausallyRelatedToTreatment>
							0
						</occurrencesCausallyRelatedToTreatment>
						<fatalities>
							<deaths>
								0
							</deaths>
							<deathsCausallyRelatedToTreatment>
								0
							</deathsCausallyRelatedToTreatment>
						</fatalities>
					</value>
					<value reportingGroupId="ReportingGroup-2">
						<occurrences>
							0
						</occurrences>
						<subjectsAffected>
							0
						</subjectsAffected>
						<subjectsExposed>
							131
						</subjectsExposed>
						<occurrencesCausallyRelatedToTreatment>
							0
						</occurrencesCausallyRelatedToTreatment>
						<fatalities>
							<deaths>
								0
							</deaths>
							<deathsCausallyRelatedToTreatment>
								0
							</deathsCausallyRelatedToTreatment>
						</fatalities>
					</value>
					<value reportingGroupId="ReportingGroup-3">
						<occurrences>
							1
						</occurrences>
						<subjectsAffected>
							1
						</subjectsAffected>
						<subjectsExposed>
							133
						</subjectsExposed>
						<occurrencesCausallyRelatedToTreatment>
							0
						</occurrencesCausallyRelatedToTreatment>
						<fatalities>
							<deaths>
								0
							</deaths>
							<deathsCausallyRelatedToTreatment>
								0
							</deathsCausallyRelatedToTreatment>
						</fatalities>
					</value>
				</values>
			</seriousAdverseEvent>
			<seriousAdverseEvent>
				<term>
					Peripheral arterial occlusive disease
				</term>
				<organSystem>
					<eutctId>
						100000004866
					</eutctId>
					<version>
						18
					</version>
				</organSystem>
				<assessmentMethod>
					<value>
						ADV_EVT_ASSESS_TYPE.systematic
					</value>
				</assessmentMethod>
				<dictionaryOverridden>
					false
				</dictionaryOverridden>
				<values>
					<value reportingGroupId="ReportingGroup-1">
						<occurrences>
							0
						</occurrences>
						<subjectsAffected>
							0
						</subjectsAffected>
						<subjectsExposed>
							132
						</subjectsExposed>
						<occurrencesCausallyRelatedToTreatment>
							0
						</occurrencesCausallyRelatedToTreatment>
						<fatalities>
							<deaths>
								0
							</deaths>
							<deathsCausallyRelatedToTreatment>
								0
							</deathsCausallyRelatedToTreatment>
						</fatalities>
					</value>
					<value reportingGroupId="ReportingGroup-2">
						<occurrences>
							1
						</occurrences>
						<subjectsAffected>
							1
						</subjectsAffected>
						<subjectsExposed>
							131
						</subjectsExposed>
						<occurrencesCausallyRelatedToTreatment>
							0
						</occurrencesCausallyRelatedToTreatment>
						<fatalities>
							<deaths>
								0
							</deaths>
							<deathsCausallyRelatedToTreatment>
								0
							</deathsCausallyRelatedToTreatment>
						</fatalities>
					</value>
					<value reportingGroupId="ReportingGroup-3">
						<occurrences>
							0
						</occurrences>
						<subjectsAffected>
							0
						</subjectsAffected>
						<subjectsExposed>
							133
						</subjectsExposed>
						<occurrencesCausallyRelatedToTreatment>
							0
						</occurrencesCausallyRelatedToTreatment>
						<fatalities>
							<deaths>
								0
							</deaths>
							<deathsCausallyRelatedToTreatment>
								0
							</deathsCausallyRelatedToTreatment>
						</fatalities>
					</value>
				</values>
			</seriousAdverseEvent>
			<seriousAdverseEvent>
				<term>
					Peripheral artery angioplasty
				</term>
				<organSystem>
					<eutctId>
						100000004865
					</eutctId>
					<version>
						18
					</version>
				</organSystem>
				<assessmentMethod>
					<value>
						ADV_EVT_ASSESS_TYPE.systematic
					</value>
				</assessmentMethod>
				<dictionaryOverridden>
					false
				</dictionaryOverridden>
				<values>
					<value reportingGroupId="ReportingGroup-1">
						<occurrences>
							1
						</occurrences>
						<subjectsAffected>
							1
						</subjectsAffected>
						<subjectsExposed>
							132
						</subjectsExposed>
						<occurrencesCausallyRelatedToTreatment>
							0
						</occurrencesCausallyRelatedToTreatment>
						<fatalities>
							<deaths>
								0
							</deaths>
							<deathsCausallyRelatedToTreatment>
								0
							</deathsCausallyRelatedToTreatment>
						</fatalities>
					</value>
					<value reportingGroupId="ReportingGroup-2">
						<occurrences>
							0
						</occurrences>
						<subjectsAffected>
							0
						</subjectsAffected>
						<subjectsExposed>
							131
						</subjectsExposed>
						<occurrencesCausallyRelatedToTreatment>
							0
						</occurrencesCausallyRelatedToTreatment>
						<fatalities>
							<deaths>
								0
							</deaths>
							<deathsCausallyRelatedToTreatment>
								0
							</deathsCausallyRelatedToTreatment>
						</fatalities>
					</value>
					<value reportingGroupId="ReportingGroup-3">
						<occurrences>
							0
						</occurrences>
						<subjectsAffected>
							0
						</subjectsAffected>
						<subjectsExposed>
							133
						</subjectsExposed>
						<occurrencesCausallyRelatedToTreatment>
							0
						</occurrencesCausallyRelatedToTreatment>
						<fatalities>
							<deaths>
								0
							</deaths>
							<deathsCausallyRelatedToTreatment>
								0
							</deathsCausallyRelatedToTreatment>
						</fatalities>
					</value>
				</values>
			</seriousAdverseEvent>
			<seriousAdverseEvent>
				<term>
					Peripheral artery stent insertion
				</term>
				<organSystem>
					<eutctId>
						100000004865
					</eutctId>
					<version>
						18
					</version>
				</organSystem>
				<assessmentMethod>
					<value>
						ADV_EVT_ASSESS_TYPE.systematic
					</value>
				</assessmentMethod>
				<dictionaryOverridden>
					false
				</dictionaryOverridden>
				<values>
					<value reportingGroupId="ReportingGroup-1">
						<occurrences>
							0
						</occurrences>
						<subjectsAffected>
							0
						</subjectsAffected>
						<subjectsExposed>
							132
						</subjectsExposed>
						<occurrencesCausallyRelatedToTreatment>
							0
						</occurrencesCausallyRelatedToTreatment>
						<fatalities>
							<deaths>
								0
							</deaths>
							<deathsCausallyRelatedToTreatment>
								0
							</deathsCausallyRelatedToTreatment>
						</fatalities>
					</value>
					<value reportingGroupId="ReportingGroup-2">
						<occurrences>
							1
						</occurrences>
						<subjectsAffected>
							1
						</subjectsAffected>
						<subjectsExposed>
							131
						</subjectsExposed>
						<occurrencesCausallyRelatedToTreatment>
							0
						</occurrencesCausallyRelatedToTreatment>
						<fatalities>
							<deaths>
								0
							</deaths>
							<deathsCausallyRelatedToTreatment>
								0
							</deathsCausallyRelatedToTreatment>
						</fatalities>
					</value>
					<value reportingGroupId="ReportingGroup-3">
						<occurrences>
							0
						</occurrences>
						<subjectsAffected>
							0
						</subjectsAffected>
						<subjectsExposed>
							133
						</subjectsExposed>
						<occurrencesCausallyRelatedToTreatment>
							0
						</occurrencesCausallyRelatedToTreatment>
						<fatalities>
							<deaths>
								0
							</deaths>
							<deathsCausallyRelatedToTreatment>
								0
							</deathsCausallyRelatedToTreatment>
						</fatalities>
					</value>
				</values>
			</seriousAdverseEvent>
			<seriousAdverseEvent>
				<term>
					Pneumonia
				</term>
				<organSystem>
					<eutctId>
						100000004862
					</eutctId>
					<version>
						18
					</version>
				</organSystem>
				<assessmentMethod>
					<value>
						ADV_EVT_ASSESS_TYPE.systematic
					</value>
				</assessmentMethod>
				<dictionaryOverridden>
					false
				</dictionaryOverridden>
				<values>
					<value reportingGroupId="ReportingGroup-1">
						<occurrences>
							0
						</occurrences>
						<subjectsAffected>
							0
						</subjectsAffected>
						<subjectsExposed>
							132
						</subjectsExposed>
						<occurrencesCausallyRelatedToTreatment>
							0
						</occurrencesCausallyRelatedToTreatment>
						<fatalities>
							<deaths>
								0
							</deaths>
							<deathsCausallyRelatedToTreatment>
								0
							</deathsCausallyRelatedToTreatment>
						</fatalities>
					</value>
					<value reportingGroupId="ReportingGroup-2">
						<occurrences>
							1
						</occurrences>
						<subjectsAffected>
							1
						</subjectsAffected>
						<subjectsExposed>
							131
						</subjectsExposed>
						<occurrencesCausallyRelatedToTreatment>
							0
						</occurrencesCausallyRelatedToTreatment>
						<fatalities>
							<deaths>
								0
							</deaths>
							<deathsCausallyRelatedToTreatment>
								0
							</deathsCausallyRelatedToTreatment>
						</fatalities>
					</value>
					<value reportingGroupId="ReportingGroup-3">
						<occurrences>
							0
						</occurrences>
						<subjectsAffected>
							0
						</subjectsAffected>
						<subjectsExposed>
							133
						</subjectsExposed>
						<occurrencesCausallyRelatedToTreatment>
							0
						</occurrencesCausallyRelatedToTreatment>
						<fatalities>
							<deaths>
								0
							</deaths>
							<deathsCausallyRelatedToTreatment>
								0
							</deathsCausallyRelatedToTreatment>
						</fatalities>
					</value>
				</values>
			</seriousAdverseEvent>
			<seriousAdverseEvent>
				<term>
					Procedural pain
				</term>
				<organSystem>
					<eutctId>
						100000004863
					</eutctId>
					<version>
						18
					</version>
				</organSystem>
				<assessmentMethod>
					<value>
						ADV_EVT_ASSESS_TYPE.systematic
					</value>
				</assessmentMethod>
				<dictionaryOverridden>
					false
				</dictionaryOverridden>
				<values>
					<value reportingGroupId="ReportingGroup-1">
						<occurrences>
							1
						</occurrences>
						<subjectsAffected>
							1
						</subjectsAffected>
						<subjectsExposed>
							132
						</subjectsExposed>
						<occurrencesCausallyRelatedToTreatment>
							0
						</occurrencesCausallyRelatedToTreatment>
						<fatalities>
							<deaths>
								0
							</deaths>
							<deathsCausallyRelatedToTreatment>
								0
							</deathsCausallyRelatedToTreatment>
						</fatalities>
					</value>
					<value reportingGroupId="ReportingGroup-2">
						<occurrences>
							0
						</occurrences>
						<subjectsAffected>
							0
						</subjectsAffected>
						<subjectsExposed>
							131
						</subjectsExposed>
						<occurrencesCausallyRelatedToTreatment>
							0
						</occurrencesCausallyRelatedToTreatment>
						<fatalities>
							<deaths>
								0
							</deaths>
							<deathsCausallyRelatedToTreatment>
								0
							</deathsCausallyRelatedToTreatment>
						</fatalities>
					</value>
					<value reportingGroupId="ReportingGroup-3">
						<occurrences>
							0
						</occurrences>
						<subjectsAffected>
							0
						</subjectsAffected>
						<subjectsExposed>
							133
						</subjectsExposed>
						<occurrencesCausallyRelatedToTreatment>
							0
						</occurrencesCausallyRelatedToTreatment>
						<fatalities>
							<deaths>
								0
							</deaths>
							<deathsCausallyRelatedToTreatment>
								0
							</deathsCausallyRelatedToTreatment>
						</fatalities>
					</value>
				</values>
			</seriousAdverseEvent>
			<seriousAdverseEvent>
				<term>
					Pyelonephritis
				</term>
				<organSystem>
					<eutctId>
						100000004862
					</eutctId>
					<version>
						18
					</version>
				</organSystem>
				<assessmentMethod>
					<value>
						ADV_EVT_ASSESS_TYPE.systematic
					</value>
				</assessmentMethod>
				<dictionaryOverridden>
					false
				</dictionaryOverridden>
				<values>
					<value reportingGroupId="ReportingGroup-1">
						<occurrences>
							0
						</occurrences>
						<subjectsAffected>
							0
						</subjectsAffected>
						<subjectsExposed>
							132
						</subjectsExposed>
						<occurrencesCausallyRelatedToTreatment>
							0
						</occurrencesCausallyRelatedToTreatment>
						<fatalities>
							<deaths>
								0
							</deaths>
							<deathsCausallyRelatedToTreatment>
								0
							</deathsCausallyRelatedToTreatment>
						</fatalities>
					</value>
					<value reportingGroupId="ReportingGroup-2">
						<occurrences>
							1
						</occurrences>
						<subjectsAffected>
							1
						</subjectsAffected>
						<subjectsExposed>
							131
						</subjectsExposed>
						<occurrencesCausallyRelatedToTreatment>
							0
						</occurrencesCausallyRelatedToTreatment>
						<fatalities>
							<deaths>
								0
							</deaths>
							<deathsCausallyRelatedToTreatment>
								0
							</deathsCausallyRelatedToTreatment>
						</fatalities>
					</value>
					<value reportingGroupId="ReportingGroup-3">
						<occurrences>
							0
						</occurrences>
						<subjectsAffected>
							0
						</subjectsAffected>
						<subjectsExposed>
							133
						</subjectsExposed>
						<occurrencesCausallyRelatedToTreatment>
							0
						</occurrencesCausallyRelatedToTreatment>
						<fatalities>
							<deaths>
								0
							</deaths>
							<deathsCausallyRelatedToTreatment>
								0
							</deathsCausallyRelatedToTreatment>
						</fatalities>
					</value>
				</values>
			</seriousAdverseEvent>
			<seriousAdverseEvent>
				<term>
					Pyelonephritis acute
				</term>
				<organSystem>
					<eutctId>
						100000004862
					</eutctId>
					<version>
						18
					</version>
				</organSystem>
				<assessmentMethod>
					<value>
						ADV_EVT_ASSESS_TYPE.systematic
					</value>
				</assessmentMethod>
				<dictionaryOverridden>
					false
				</dictionaryOverridden>
				<values>
					<value reportingGroupId="ReportingGroup-1">
						<occurrences>
							0
						</occurrences>
						<subjectsAffected>
							0
						</subjectsAffected>
						<subjectsExposed>
							132
						</subjectsExposed>
						<occurrencesCausallyRelatedToTreatment>
							0
						</occurrencesCausallyRelatedToTreatment>
						<fatalities>
							<deaths>
								0
							</deaths>
							<deathsCausallyRelatedToTreatment>
								0
							</deathsCausallyRelatedToTreatment>
						</fatalities>
					</value>
					<value reportingGroupId="ReportingGroup-2">
						<occurrences>
							0
						</occurrences>
						<subjectsAffected>
							0
						</subjectsAffected>
						<subjectsExposed>
							131
						</subjectsExposed>
						<occurrencesCausallyRelatedToTreatment>
							0
						</occurrencesCausallyRelatedToTreatment>
						<fatalities>
							<deaths>
								0
							</deaths>
							<deathsCausallyRelatedToTreatment>
								0
							</deathsCausallyRelatedToTreatment>
						</fatalities>
					</value>
					<value reportingGroupId="ReportingGroup-3">
						<occurrences>
							1
						</occurrences>
						<subjectsAffected>
							1
						</subjectsAffected>
						<subjectsExposed>
							133
						</subjectsExposed>
						<occurrencesCausallyRelatedToTreatment>
							0
						</occurrencesCausallyRelatedToTreatment>
						<fatalities>
							<deaths>
								0
							</deaths>
							<deathsCausallyRelatedToTreatment>
								0
							</deathsCausallyRelatedToTreatment>
						</fatalities>
					</value>
				</values>
			</seriousAdverseEvent>
			<seriousAdverseEvent>
				<term>
					Pyrexia
				</term>
				<organSystem>
					<eutctId>
						100000004867
					</eutctId>
					<version>
						18
					</version>
				</organSystem>
				<assessmentMethod>
					<value>
						ADV_EVT_ASSESS_TYPE.systematic
					</value>
				</assessmentMethod>
				<dictionaryOverridden>
					false
				</dictionaryOverridden>
				<values>
					<value reportingGroupId="ReportingGroup-1">
						<occurrences>
							0
						</occurrences>
						<subjectsAffected>
							0
						</subjectsAffected>
						<subjectsExposed>
							132
						</subjectsExposed>
						<occurrencesCausallyRelatedToTreatment>
							0
						</occurrencesCausallyRelatedToTreatment>
						<fatalities>
							<deaths>
								0
							</deaths>
							<deathsCausallyRelatedToTreatment>
								0
							</deathsCausallyRelatedToTreatment>
						</fatalities>
					</value>
					<value reportingGroupId="ReportingGroup-2">
						<occurrences>
							1
						</occurrences>
						<subjectsAffected>
							1
						</subjectsAffected>
						<subjectsExposed>
							131
						</subjectsExposed>
						<occurrencesCausallyRelatedToTreatment>
							0
						</occurrencesCausallyRelatedToTreatment>
						<fatalities>
							<deaths>
								0
							</deaths>
							<deathsCausallyRelatedToTreatment>
								0
							</deathsCausallyRelatedToTreatment>
						</fatalities>
					</value>
					<value reportingGroupId="ReportingGroup-3">
						<occurrences>
							0
						</occurrences>
						<subjectsAffected>
							0
						</subjectsAffected>
						<subjectsExposed>
							133
						</subjectsExposed>
						<occurrencesCausallyRelatedToTreatment>
							0
						</occurrencesCausallyRelatedToTreatment>
						<fatalities>
							<deaths>
								0
							</deaths>
							<deathsCausallyRelatedToTreatment>
								0
							</deathsCausallyRelatedToTreatment>
						</fatalities>
					</value>
				</values>
			</seriousAdverseEvent>
			<seriousAdverseEvent>
				<term>
					Schizophrenia
				</term>
				<organSystem>
					<eutctId>
						100000004873
					</eutctId>
					<version>
						18
					</version>
				</organSystem>
				<assessmentMethod>
					<value>
						ADV_EVT_ASSESS_TYPE.systematic
					</value>
				</assessmentMethod>
				<dictionaryOverridden>
					false
				</dictionaryOverridden>
				<values>
					<value reportingGroupId="ReportingGroup-1">
						<occurrences>
							1
						</occurrences>
						<subjectsAffected>
							1
						</subjectsAffected>
						<subjectsExposed>
							132
						</subjectsExposed>
						<occurrencesCausallyRelatedToTreatment>
							0
						</occurrencesCausallyRelatedToTreatment>
						<fatalities>
							<deaths>
								0
							</deaths>
							<deathsCausallyRelatedToTreatment>
								0
							</deathsCausallyRelatedToTreatment>
						</fatalities>
					</value>
					<value reportingGroupId="ReportingGroup-2">
						<occurrences>
							0
						</occurrences>
						<subjectsAffected>
							0
						</subjectsAffected>
						<subjectsExposed>
							131
						</subjectsExposed>
						<occurrencesCausallyRelatedToTreatment>
							0
						</occurrencesCausallyRelatedToTreatment>
						<fatalities>
							<deaths>
								0
							</deaths>
							<deathsCausallyRelatedToTreatment>
								0
							</deathsCausallyRelatedToTreatment>
						</fatalities>
					</value>
					<value reportingGroupId="ReportingGroup-3">
						<occurrences>
							0
						</occurrences>
						<subjectsAffected>
							0
						</subjectsAffected>
						<subjectsExposed>
							133
						</subjectsExposed>
						<occurrencesCausallyRelatedToTreatment>
							0
						</occurrencesCausallyRelatedToTreatment>
						<fatalities>
							<deaths>
								0
							</deaths>
							<deathsCausallyRelatedToTreatment>
								0
							</deathsCausallyRelatedToTreatment>
						</fatalities>
					</value>
				</values>
			</seriousAdverseEvent>
			<seriousAdverseEvent>
				<term>
					Sinusitis
				</term>
				<organSystem>
					<eutctId>
						100000004862
					</eutctId>
					<version>
						18
					</version>
				</organSystem>
				<assessmentMethod>
					<value>
						ADV_EVT_ASSESS_TYPE.systematic
					</value>
				</assessmentMethod>
				<dictionaryOverridden>
					false
				</dictionaryOverridden>
				<values>
					<value reportingGroupId="ReportingGroup-1">
						<occurrences>
							1
						</occurrences>
						<subjectsAffected>
							1
						</subjectsAffected>
						<subjectsExposed>
							132
						</subjectsExposed>
						<occurrencesCausallyRelatedToTreatment>
							0
						</occurrencesCausallyRelatedToTreatment>
						<fatalities>
							<deaths>
								0
							</deaths>
							<deathsCausallyRelatedToTreatment>
								0
							</deathsCausallyRelatedToTreatment>
						</fatalities>
					</value>
					<value reportingGroupId="ReportingGroup-2">
						<occurrences>
							0
						</occurrences>
						<subjectsAffected>
							0
						</subjectsAffected>
						<subjectsExposed>
							131
						</subjectsExposed>
						<occurrencesCausallyRelatedToTreatment>
							0
						</occurrencesCausallyRelatedToTreatment>
						<fatalities>
							<deaths>
								0
							</deaths>
							<deathsCausallyRelatedToTreatment>
								0
							</deathsCausallyRelatedToTreatment>
						</fatalities>
					</value>
					<value reportingGroupId="ReportingGroup-3">
						<occurrences>
							0
						</occurrences>
						<subjectsAffected>
							0
						</subjectsAffected>
						<subjectsExposed>
							133
						</subjectsExposed>
						<occurrencesCausallyRelatedToTreatment>
							0
						</occurrencesCausallyRelatedToTreatment>
						<fatalities>
							<deaths>
								0
							</deaths>
							<deathsCausallyRelatedToTreatment>
								0
							</deathsCausallyRelatedToTreatment>
						</fatalities>
					</value>
				</values>
			</seriousAdverseEvent>
			<seriousAdverseEvent>
				<term>
					Spondylolisthesis
				</term>
				<organSystem>
					<eutctId>
						100000004859
					</eutctId>
					<version>
						18
					</version>
				</organSystem>
				<assessmentMethod>
					<value>
						ADV_EVT_ASSESS_TYPE.systematic
					</value>
				</assessmentMethod>
				<dictionaryOverridden>
					false
				</dictionaryOverridden>
				<values>
					<value reportingGroupId="ReportingGroup-1">
						<occurrences>
							0
						</occurrences>
						<subjectsAffected>
							0
						</subjectsAffected>
						<subjectsExposed>
							132
						</subjectsExposed>
						<occurrencesCausallyRelatedToTreatment>
							0
						</occurrencesCausallyRelatedToTreatment>
						<fatalities>
							<deaths>
								0
							</deaths>
							<deathsCausallyRelatedToTreatment>
								0
							</deathsCausallyRelatedToTreatment>
						</fatalities>
					</value>
					<value reportingGroupId="ReportingGroup-2">
						<occurrences>
							1
						</occurrences>
						<subjectsAffected>
							1
						</subjectsAffected>
						<subjectsExposed>
							131
						</subjectsExposed>
						<occurrencesCausallyRelatedToTreatment>
							0
						</occurrencesCausallyRelatedToTreatment>
						<fatalities>
							<deaths>
								0
							</deaths>
							<deathsCausallyRelatedToTreatment>
								0
							</deathsCausallyRelatedToTreatment>
						</fatalities>
					</value>
					<value reportingGroupId="ReportingGroup-3">
						<occurrences>
							0
						</occurrences>
						<subjectsAffected>
							0
						</subjectsAffected>
						<subjectsExposed>
							133
						</subjectsExposed>
						<occurrencesCausallyRelatedToTreatment>
							0
						</occurrencesCausallyRelatedToTreatment>
						<fatalities>
							<deaths>
								0
							</deaths>
							<deathsCausallyRelatedToTreatment>
								0
							</deathsCausallyRelatedToTreatment>
						</fatalities>
					</value>
				</values>
			</seriousAdverseEvent>
			<seriousAdverseEvent>
				<term>
					Weight decreased
				</term>
				<organSystem>
					<eutctId>
						100000004848
					</eutctId>
					<version>
						18
					</version>
				</organSystem>
				<assessmentMethod>
					<value>
						ADV_EVT_ASSESS_TYPE.systematic
					</value>
				</assessmentMethod>
				<dictionaryOverridden>
					false
				</dictionaryOverridden>
				<values>
					<value reportingGroupId="ReportingGroup-1">
						<occurrences>
							1
						</occurrences>
						<subjectsAffected>
							1
						</subjectsAffected>
						<subjectsExposed>
							132
						</subjectsExposed>
						<occurrencesCausallyRelatedToTreatment>
							1
						</occurrencesCausallyRelatedToTreatment>
						<fatalities>
							<deaths>
								0
							</deaths>
							<deathsCausallyRelatedToTreatment>
								0
							</deathsCausallyRelatedToTreatment>
						</fatalities>
					</value>
					<value reportingGroupId="ReportingGroup-2">
						<occurrences>
							0
						</occurrences>
						<subjectsAffected>
							0
						</subjectsAffected>
						<subjectsExposed>
							131
						</subjectsExposed>
						<occurrencesCausallyRelatedToTreatment>
							0
						</occurrencesCausallyRelatedToTreatment>
						<fatalities>
							<deaths>
								0
							</deaths>
							<deathsCausallyRelatedToTreatment>
								0
							</deathsCausallyRelatedToTreatment>
						</fatalities>
					</value>
					<value reportingGroupId="ReportingGroup-3">
						<occurrences>
							0
						</occurrences>
						<subjectsAffected>
							0
						</subjectsAffected>
						<subjectsExposed>
							133
						</subjectsExposed>
						<occurrencesCausallyRelatedToTreatment>
							0
						</occurrencesCausallyRelatedToTreatment>
						<fatalities>
							<deaths>
								0
							</deaths>
							<deathsCausallyRelatedToTreatment>
								0
							</deathsCausallyRelatedToTreatment>
						</fatalities>
					</value>
				</values>
			</seriousAdverseEvent>
		</seriousAdverseEvents>
	</adverseEvents>
</result>
